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ABSTRACT 
 
Background. Effects of lifestyle interventions on early biomarkers of oxidative stress 
and CVD risk in youth with prediabetes are unknown. Objective. To evaluate the effects 
of a lifestyle intervention to prevent type 2 diabetes among obese prediabetic Latino 
adolescents on oxidized lipoproteins. Design: In a quasi-experimental design, 35 
adolescents (51.4% male, age 15.5(1.0) y, body mass index (BMI) percentile 98.5(1.2), 
and glucose 2 hours after an oral glucose tolerance test-OGTT 141.2(12.2) mg/dL) 
participated in a 12-week intervention that included weekly exercise (three 60 min-
sessions) and nutrition education (one 60 min-session). Outcomes measured at baseline 
and post-intervention were: fasting oxidized LDL and oxidized HDL (oxLDL and 
oxHDL) as oxidative stress variables; dietary intake of fresh fruit and vegetable (F&V) 
and fitness (VO2max) as behavioral variables; weight, BMI, body fat, and waist 
circumference as anthropometric variables; fasting glucose and insulin, 2hour glucose 
and insulin after an OGTT, insulin resistance (HOMA-IR), and lipid panel (triglycerides, 
total cholesterol, VLDL-c, LDL-c, HDL-c, and Non-HDL) as cardiometabolic variables. 
Results. Comparing baseline to post-intervention, significant decreases in oxLDL 
concentration were shown (51.0(14.0) and 48.7(12.8) U/L, p=0.022); however, the 
intervention did not decrease oxHDL (395.2(94.6) and 416.1(98.4) ng/mL, p=0.944). 
F&V dietary intake (116.4(97.0) and 165.8(91.0) g/d, p=0.025) and VO2max (29.7(5.0) 
and 31.6(4.7) ml*kg-1*min-1, p<0.001) significantly increased. Within-subjects 
correlations between changes in F&V intake and oxidized lipoproteins, adjusted for 
VO2max changes, were non-significant (R=-0.15, p=0.52 for oxLDL; R=0.22, p=0.25 for 
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oxHDL). Anthropometric variables were significantly reduced (weight -1.3% p=0.042; 
BMI -2.2% and BMI percentile -0.4%, p=0.001; body fat -6.6% and waist circumference 
-1.8%, p=0.025). Cardiometabolic variables significantly improved, including reductions 
in glucose 2hour (-19.3% p<0.001), fasting insulin (-12.9% p=0.008), insulin 2hour (-
53.5% p<0.001), and HOMA-IR (-12.5% p=0.015), with 23 participants (66%) that 
reverted toward a normal glucose tolerance status. Most lipid panel significantly changed 
(triglycerides -10.2% p=0.032; total cholesterol -5.4% p=0.002; VLDL-c -10.4% 
p=0.029; HDL-c -3.2% p=0.022; and Non-HDL -5.5% p=0.0007).  Conclusion. The 
intervention resulted in differential effects on oxidized lipoproteins and significant 
improvements in behavioral, anthropometric and cardiometabolic variables, reducing the 
high metabolic risk of obese prediabetic kids. 
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CHAPTER 1. INTRODUCTION 
 
1.1 Background 
 Atherosclerosis is the initial hallmark of cardiovascular diseases (CVD), which 
are the major source of morbidity and mortality globally.1 In 2014, the World Health 
Organization (WHO) reported that 17.5 million people die from CVD yearly. CVD 
accounted for an estimated of 31% of all deaths, representing the number one cause 
worldwide.2 The proportion is similar in the U.S., where CVD causes almost 801,000 
deaths (approximately 1 out of 3 deaths) every year.3 
 In regards to morbidity, in the U.S. about 92.1 million American adults have some 
form of CVD or survived a stroke. Projections are not positive, since 43.9% of the U.S. 
population by 2030 are expected to have some form of CVD.3 Regarding economic 
burdens, an estimated of more than $316 billion represents direct and indirect CVD costs, 
which includes health care and loss of productivity.4 Hence, CVD represents the 
condition with the most expensive health-care cost and to which more deaths are 
attributed. Therefore, it is essential to take actions against CVD in a preventive manner. 
 Recommendations from the American Heart Association (AHA) to prevent CVD 
are mainly focused on reducing risk factors. These are obesity, hypercholesterolemia 
(mainly elevated low-density lipoprotein cholesterol concentration, LDL-c), 
hypertension, low high-density lipoprotein cholesterol concentration (HDL-c), and 
diabetes mellitus (DM).5,6 The current elevated prevalence of diabetes and obesity are 
projected to contribute raising the atherosclerosis estimates in the near future.7,8 
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 Regarding CVD risk by ethnic group, in the most recent Heart and Stroke 
Statistics reports from the AHA Latinos showed elevated estimates of cardiometabolic 
risk factors such as obesity, hypercholesterolemia, high blood pressure, diagnosed DM, 
and low physical activity (PA) levels, compared to non-Latino white adults.4,9,10 
Furthermore, in a recent study Latinos had a low-CV risk profile, an ideal metric for 
preventing cardiometabolic diseases.11 Besides, Latinos have elevated genetic 
susceptibility for type 2 diabetes (T2D) according to some identified single nuclear 
polymorphisms, compared to other ethnic groups.12 The CV risk in Latinos is even 
greater considering that this group is a minority with low income and low education,13 
who also have limited access to medical care and consequently lack of health-related 
information.14 Undoubtedly, Latinos are among the most vulnerable groups for CVD.15-17 
 Combating the risk for CVD entails huge efforts from healthcare systems 
worldwide, but especially to communities with a high proportion of Latinos, such as 
U.S.18-20 Latinos are the youngest major ethnic group in U.S.,21 and in Arizona Latinos 
comprise 40.8% of the population.22 Being Phoenix the 6th most crowded city across the 
nation,23 the economic burden for the health system in Arizona to combat CVD is even 
greater than for other states in U.S.24 
 Despite that evident CVD seldom emerge before adulthood, early atherosclerotic 
manifestations can be seen during childhood and youth,25-27 especially in individuals with 
diabetes.28 These early manifestations represent the main concern for children because 
during last decades childhood obesity and diabetes have reached epidemic proportions.29-
31 In this sense, Latino children are at a substantial CV risk because of the elevated 
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prevalence of obesity, T2D, and cardiometabolic factors,32,33 as well as the health-
disparities that Latino children face.34 According to Dabelea et al.,35 in five areas of the 
U.S., the prevalence of T2D among Latino youth was 0.79 per 1000 youth in 2009, being 
the greatest increase from 2001 to 2009, compared to other ethnic groups. Additionally, 
according to the 1999-2014 NHANES data in adolescents from 12-19 y old, Hispanics 
had greater prevalence of overweight and obesity (22.8% and 8.8%), compared to non-
Hispanic whites (19.6% and 6.7%).32 Furthermore, the 2005-2014 NHANES data showed 
a weighted prevalence of diabetes of 0.76% and a prevalence of prediabetes of 22.9%, 
compared to non-Hispanic whites (0.6% and 15.1%, respectively).36 Hence, Latino 
children represent a high-risk group for atherosclerosis and CVD, as Latino adults do, and 
unfortunately Latino children will probably account for most T2DM and CVD cases as 
adults in the near future.37 Despite this increased cardiometabolic risk in Latino children, 
most studies in Latinos are targeting adult populations with frank CVD, with just few 
documented studies at early ages mainly focused on endothelial dysfunction associated 
with cardiometabolic risk factors.38-42 
 Atherosclerosis, which initiates CVD, is defined as a chronic, progressive, and 
multifactorial disease caused by complex and interrelated etiological factors that affect 
large and medium-sized arteries. It is characterized by the accumulation of fatty 
substances, cholesterol deposits, inflammatory and chemotactic proteins, cellular waste 
products, calcium, and fibrin in the intima layer of arteries.43 In atherosclerosis 
lipoprotein metabolism plays a pivotal role, since atherosclerotic lesions are promoted by 
low-density lipoproteins, and are hindered by high-density lipoproteins.44 
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 A lipoprotein is defined as “a spherical particle that is used for the transfer of 
lipids and lipophilic substances in the circulation. It is composed of various amounts of 
phospholipids, cholesterol, and triglycerides as well as apoproteins.”45 Lipoproteins are 
complexes of amphipathic proteins with lipids at variable ratios, densities, and sizes. 
Their main function is to transport water-insoluble lipids between cells and organs 
through the lymph and blood. Plasma lipoproteins have traditionally been grouped into 
five major classes, based on their buoyant density: chylomicrons, very low-density 
lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins 
(LDL), and high-density lipoproteins (HDL).44 Enterocytes and hepatocytes package 
cholesterol and cholesteryl esters into lipoproteins of various sizes and compositions that 
are further modified in the circulation. Lipoproteins are synthesized and catabolized in 
three distinct pathways: the chylomicron pathway, the VLDL/LDL/IDL pathway, and the 
HDL pathway, all of which are metabolically interrelated.46  
 Atherosclerosis starts when LDL particles, especially those small and dense, 
traverse the endothelium and are retained by proteoglycans in the inner lining of arterial 
walls. Once LDL particles are retained, oxidative enzymes such as myeloperoxidase 
(MPO) oxidize them.  These oxidized LDL (oxLDL) particles are able to recruit 
inflammatory cells such as monocytes, which adhere to the surface of the endothelium 
and transmigrate into the intima layer. At this site, monocytes proliferate, differentiate 
into macrophages and form foam cells via up taking of lipoproteins, promoting the 
atherosclerotic lesion through the production of chemotactic proteins, deposition of 
cholesterol, and the continued recruitment of inflammatory cells. These set of cells 
perpetuate inflammatory and oxidative responses together with a gradual and slow 
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thickening of the wall, impeding blood flow in the vessel lumen.47,48 The regular blood 
flow causes physical forces such as shear stress, which disrupts the atherosclerotic lesion 
and allows its elements to be exposed to circulation.49 The atherosclerotic components 
can travel throughout the arterial system, resulting in thrombosis and compromising 
oxygen supply in target organs like heart and brain.50 This process can lead to multiple 
fatal consequences such as hemorrhage, rupture, calcification, and thrombosis.51 
 Regarding the role of HDL in atherosclerosis, its main beneficial effect is 
attributed to a mechanism called “reverse cholesterol transport”, in which HDL mediates 
the transfer of cholesterol from LDL, VLDL, and macrophages in the artery wall to be 
transported and degraded to the liver, and finally excreted into the bile.52,53 Experimental 
assays have shown other beneficial effects for HDL particles, such as impediment of 
LDL oxidation in endothelial and smooth muscle cell cultures and suppression of the 
expression of chemotactic factors.54 The favorable effects of HDL in atherosclerosis, such 
as cholesterol efflux, antiinflammation, and antioxidation, are mainly associated with 
small and dense HDL particles.55,56 These small particles are rich in antioxidant enzymes 
and antioxidant proteins such as paraoxonase-1 (PON-1), apoL-I and apoA-I.57 Actually 
PON-1 in HDL in an experimental assay prevented the accumulation of lipid 
hydroperoxides on LDL.58 However, HDL particles can also be oxidized by prooxidant 
enzymes such as MPO and by ROS, transforming the favorable HDL particles into 
dysfunctional oxidized HDL (oxHDL) particles that are unable to induce all the 
aforementioned benefits.59-62 
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  Besides lipoprotein oxidation, there are certain metabolic conditions that 
intensify atherosclerosis, such as insulin resistance and hyperglycemia, which are closely 
related to the progression of T2D. In fact, in diabetic people the risk of coronary 
atherosclerosis is three- to five-fold higher comparing to non-diabetics, after controlling 
for other variables.63,64 Insulin resistance and hyperglycemia may promote both 
atherogenesis and advanced plaque progression. Moreover, insulin resistance and 
hyperglycemia are likely to have additive or synergistic pro-atherogenic effects.65,66 
Insulin resistance is clinically defined as “the inability of a known quantity of exogenous 
or endogenous insulin to increase glucose uptake and utilization in an individual as much 
as it does in a normal population.”67 The processes by which insulin resistance promote 
atherosclerosis involve both systemic effects (particularly dyslipidemia, but also 
hypertension and a pro-inflammatory state), as well as impaired insulin signaling (both 
down- and up-regulation of insulin receptor signaling). The impairment of insulin 
receptor-mediated signaling occurs at the level of the intimal cells and includes 
endothelial cells, vascular smooth muscle cells, and macrophages.65,68 
 In systemic insulin resistance-induced dyslipidemia, free fatty acids (FFAs) rise at 
circulation due to the loss of suppressive effects of insulin on lipolysis in adipocytes. 
FFAs are then transported to the liver, promoting the production of VLDLs. Moreover, 
lipoprotein lipase action is reduced in insulin resistance, which is an enzyme found in the 
endothelium of peripheral capillaries that is rate-limiting for the clearance of triglyceride-
rich lipoproteins. As a consequence, hypertriglyceridemia occurs in insulin resistance, 
reflecting elevated VLDL particles which when metabolized, promote atheroma 
formation. The presence of elevated VLDL particles also affects HDL metabolism. 
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Triglycerides in VLDL are transferred to HDL through the action of cholesteryl ester 
transfer protein (CETP), resulting in a triglyceride-enriched HDL particle that is more 
rapidly cleared from the circulation. This leaves fewer HDL particles to accept 
cholesterol from the vasculature, then promoting atherogenesis.66,69  
 In regards to hyperglycemia, although evidence from human and animal studies is 
not as strong as that for insulin resistance, there are studies supporting a direct pro-
atherogenic role of hyperglycemia at the level of the endothelium. Data suggest that 
hyperglycemia in the setting of a non-diabetes-mediated hypercholesterolemic 
background is enough to promote early lesion formation. However, diabetes-induced 
elevation of atherogenic lipoproteins are required to accelerate progression of advanced 
plaques in diabetic mice, beyond that normally observed in non-diabetic mice.65 
 Besides, the frequent excess of caloric intake usually present in obesity and T2D 
particularly affects pancreatic β-cells and endothelial cells, leading to their dysfunction. 
The elevated glucose and FFA concentrations on pancreatic β-cells inhibit essential 
cellular elements for first-phase insulin production, suppressing the insulin secretion 
through processes known as glucotoxicity and lipotoxicity.70 Once these processes 
become irreversible, they cause fatal islet cell injury and acceleration of β-cell loss, with 
openly impaired action and secretion of insulin.71,72 All the effects of insulin resistance 
and hyperglycemia on the endothelium perpetuate the vascular complications of T2D. 
  The proposed mechanisms by which obesity, insulin resistance, hyperglycemia, 
and T2D adversely affect the endothelium are oxidative stress and inflammation.73,74 
Oxidative stress is defined as “an imbalance between oxidants and antioxidants in favor 
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of the oxidants, potentially leading to damage.”75 Oxidative stress is a condition in which 
reactive oxygen species (ROS) and reactive nitrogen species (RNS) are overproduced, as 
well as other free-radical oxidants. These oxidants are able to promote further oxidation 
of biological molecules, such as proteins, lipids, and DNA.76 The suggested factors 
triggering oxidative stress are the excessive caloric intake and lack of PA that are present 
in obesity and T2D. The surplus of nutrients produces a substrate-induced increase in 
citric-acid cycle activity, generating an excess of mitochondrial NADH (the reduced form 
of nicotinamide adenine dinucleotide). The excess of NADH yields the consequent 
overproduction of free radicals, particularly superoxide anion radical, and ROS, leading 
to an oxidative imbalance. Moreover, in diabetes, the excessive production of oxidants is 
intensified by the low expression of antioxidant enzymes.77,78 
 Within the endothelium, the overproduction of superoxide anion radical is 
accompanied by the higher production of nitric oxide, favoring the generation of 
peroxynitrite, a potent oxidant that can cause DNA fragmentation and lipid peroxidation, 
ultimately resulting in acute endothelial dysfunction.79 Besides, excessive superoxide 
anion disrupts the balance between dilation and constriction. With this imbalance, the 
vasculature suffers severe pro-atherogenic changes, such as vasoconstriction, lipoprotein 
oxidation, leukocyte adherence, inflammation, and some other diverse abnormalities, 
which are essential steps in atherosclerosis.80,81  
 Among all the aforementioned pro-atherogenic changes caused by oxidative 
stress, the oxidation of lipoproteins is of paramount importance given their role in 
atherosclerosis. Furthermore, due to their chemical composition lipoproteins are 
especially susceptible to oxidative stress, leading to increased concentrations of oxLDL 
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and oxHDL.82,83 As reported previously, investigations have proposed oxLDL particles as 
precursors of atherosclerotic lesions.84-87 There are multiple studies in adults in which 
oxLDL has been associated with CV events86-91 and also found as a predictor of these 
events.92,93 In regard to oxHDL, experimental studies have shown it as a dysfunctional 
particle unable to carry out reverse cholesterol transport and to counteract the oxidation 
of LDL.94-96 Additionally, although fewer investigations than those regarding oxLDL, 
some studies with cross-sectional data in adults have still shown significant greater 
oxHDL concentrations in cardiometabolic conditions such as obesity and liver fat, 
compared to overweight/obese and to normal weight individuals.97,98 Despite the fact that 
both lipoproteins have been found in atherosclerotic lesions in experimental studies, and 
the independent associations that oxLDL has shown with CVD and oxHDL with some 
cardiometabolic conditions, research in humans accounting for the synergistic 
associations of both oxidized lipoproteins with cardiometabolic risk are extremely 
limited, and studies in youth are even scarcer. Only a research by Marin et al. (2015) has 
reported levels of both oxidized lipoproteins in overweight/obese youths and obese T2D 
kids, compared to normal weight control. Therefore, it is crucial to do comprehensive 
research that accounts for synergistic associations of oxidized lipoproteins with 
cardiometabolic conditions.   
 Concerning pediatric population, various cross-sectional studies in children and 
adolescents have analyzed differences in oxLDL concentration among groups, such as 
overweight and obese,99-102 severely obese,103,104 non-alcoholic fatty liver disease 
(NAFLD),105 and diabetics,106-108 compared to normal weight group. Most studies have 
shown significant differences between groups, with greater levels of oxLDL in 
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metabolically impaired individuals such as NAFLD and diabetics, as well as in 
overweight/obese kids, when these groups are compared to control normal-weight 
groups. However, no significant differences in oxLDL between groups have also been 
documented.109  
 In contrast, studies investigating oxHDL have been scarce, with three studies in 
adults: two from the Cardiovascular Risk in Young Finns Study98,110 and one with female 
adults compared to normal weight.97 From The Young Finns Study, Kresanov et al. 
(2013) showed an inverse association between oxHDL and age, insulin, and waist 
circumference, respectively.110 The same research group reported a high oxidation score 
directly associated with fatty liver in a study published by Kaikkonen et al.98 In the study 
with adult females, obese patients displayed a 6-fold increase in oxHDL compared to 
normal weight, and the oxHDL/total HDL ratio increased with increasing BMI.97 
Regarding pediatric population, only one study has compared oxHDL concentrations 
among normal weight, obese, and obese+T2D adolescents.107 In this, oxHDL was 65% 
higher in the obese+T2D group, compared to the normal weight group and with the 
obese-only group. In this latter study, oxHDL was not correlated with insulin resistance 
(HOMA-IR), while oxLDL and lean body mass were positively associated with 
oxHDL.107 
 Concerning interventions to decrease oxidation through lowering oxidative stress 
levels, these are focused on improving the antioxidant defense system of individuals. The 
improvement may be reached by either augmenting the endogenous enzymatic 
antioxidants, mainly by exercise, or increasing the intake of antioxidant nutrients by 
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promoting a diet rich in fruit and vegetables, or both.111,112 Interventions to improve the 
antioxidant defense system have been documented in the adult population, as well as in 
youth. In the pediatric population, interventions reducing oxidative stress levels have 
used dietary modification only,113-116 exercise only,117,118 lifestyle modifications (diet and 
exercise),119,120 and bariatric surgery.121,122 The effects of these interventions have also 
been explored on different health conditions. Hypercholesterolemia,123 non-alcoholic 
fatty liver disease (NAFLD),116,124 overweight/obesity,119,120 and severe obesity,114,121,122 
are some of the conditions in which pediatric interventions have been evaluated. It is 
worth mentioning that despite the preponderant role that hyperglycemia has on oxidative 
stress, up to current knowledge no intervention addressing either prediabetics or T2D 
children have been documented. 
 With respect to exercise, interventions have resulted in significant decreases in 
pro-oxidant parameters and increases in enzymatic antioxidant capacity with aerobic and 
endurance exercise.125-128 Regarding dietary modifications, studies have tested 
antioxidant-rich foods such as increases in fruit and vegetable consumption, 
supplementation, and caloric restriction, with most research resulting in significant 
reductions in oxidative stress after the intervention.123,129,130 Using both exercise training 
and dietary modification within the same intervention has seemed to be more effective 
decreasing oxidative stress than using only exercise or diet, particularly in the youth 
population.119,120,131,132 Moreover, including supplementation with antioxidants on 
lifestyle interventions has been beneficial decreasing oxidative stress.115,116 It has been 
suggested that additive and/or synergistic effects are present in these comprehensive 
interventions that include both exercise and antioxidants. 
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 With respect to interventions specifically decreasing oxidized lipoproteins in 
children and adolescents, oxLDL has been more frequently analyzed in programs using 
exercise,118 dietary modifications,124,130 supplements,129 lifestyle modifications,119,120 and 
bariatric surgery.121 Once again, most interventions but not all have demonstrated 
beneficial results decreasing oxLDL,120,121,124 and findings from some few interventions 
showed no reductions in oxidized lipoproteins133 or authors needed to divide participants 
into responders and non-responders to show effects.130 Regarding studies in youth 
measuring oxHDL have been scant and mainly related to HDL function. Two 
interventions consisted of measuring the effect of a lifestyle intervention on HDL-
cholesterol efflux capacity,134 and the effect of bariatric surgery on HDL function.122 
Both interventions resulted in beneficial effects on HDL functions. 
 Globally, results from most interventions previously mentioned effectively have 
induced significant decreases in oxidative stress in youth.117,133,135 Nevertheless, some 
studies have shown no effects on oxidative stress in the pediatric population.118,121,122	  It is 
important mentioning that interventions have differed in its components, making them 
also different in nature. The differences include characteristics of participants, type of 
intervention (dietary, exercise, or diet and exercise together), intensity and duration of 
intervention, inclusion or not of the family within the program, among other elements. 
All these differences may make studies difficult to compare when addressing the same 
type of individuals. Moreover, the use of different biomarkers is also an important 
difference since oxidative stress can cause multiple oxidation reactions and can affect 
different types of molecules. It must be commented that lipoprotein oxidation as response 
outcome from an intervention is of paramount importance in the context of oxidative 
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stress, insulin resistance, hyperglycemia, and atherosclerosis. The proposed roles of 
oxLDL in the initiation of an atherosclerotic lesion and oxHDL as an impaired molecule 
unable to counteract the oxidation of LDL, make interventions addressing these 
molecules being essential.  
 Collectively, findings from studies reported here indicate that more research needs 
to be done within the context of interventions reducing early atherosclerotic biomarkers 
related to oxidative stress. Among all reactions and processes associated with 
atherosclerosis herein mentioned, lipoprotein oxidation is of fundamental value because 
of their role in the atherosclerotic lesions. It is imperative to execute research in an early-
age population with increased CVD risks, such as those with obesity, insulin resistance, 
and hyperglycemia. Research is necessary in order to guarantee that exercise training and 
dietary antioxidants promote beneficial changes in the oxidative environment of young 
high-risk individuals, thereby reducing levels of oxidative stress in the pediatric 
population. 
 Accordingly, up to current knowledge no lifestyle intervention involving the 
promotion of fruit and vegetable intake and exercise training has been evaluated in obese 
prediabetic Latino youth, which are at high risk for developing CVD due to obesity, 
insulin resistance, and as well as the hyperglycemic state, which are metabolic conditions 
that promote oxidative stress. Even though oxidative stress is one of the mechanisms 
underlying the gradual development and progression of atherosclerosis and diabetic 
complications, no studies exist testing the effects of lifestyle interventions on both ox 
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LDL and oxHDL as early oxidative stress biomarkers of atherosclerosis in obese 
prediabetic Latino youth.  
 
1.2 Purpose of Research 
 Considering the high risk for CVD at which obese, insulin resistant and 
hyperglycemic people are, particularly some ethnic minorities like Latinos, there is an 
urgent need to promote prevention interventions, especially at childhood. The evaluation 
of the effects of a T2D-prevention intervention on levels of oxLDL and oxHDL as early 
biomarkers of atherosclerotic risk represents an ideal approach for investigating how 
oxidative stress is affected by lifestyle modifications. Therefore, the purpose of this study 
was to evaluate the effects of a lifestyle and T2D-prevention intervention for obese 
prediabetic Latino adolescents on levels of oxidized lipoproteins as early biomarkers of 
oxidative stress.  
 
1.3 Specific Aims and Hypotheses 
1.3.1 Specific Aim 1. To analyze the effect of a lifestyle and T2D-prevention 
intervention for obese prediabetic Latino adolescents on concentrations of oxLDL. 
 Hypothesis 1. OxLDL concentration will be significantly lower after a lifestyle and 
T2D-prevention intervention in obese prediabetic Latino adolescents, compared to 
baseline. 
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1.3.2 Specific Aim 2. To analyze the effect of a lifestyle and T2D-prevention 
intervention for obese prediabetic Latino adolescents on concentrations of oxHDL. 
 Hypothesis 2. OxHDL concentration will be significantly lower after a lifestyle and 
T2D-prevention intervention in obese prediabetic Latino adolescents, compared to 
baseline. 
1.3.3 Specific Aim 3. To explore how changes in dietary intake of fresh fruit and 
vegetable (F&V) after a lifestyle and T2D-prevention intervention are significantly 
correlated with changes in oxLDL and oxHDL in obese prediabetic Latino 
adolescents, after controlling for changes in cardiorespiratory fitness. 
 Hypothesis 3. Changes in dietary intake of fresh F&V will inversely and 
independently correlate with changes in oxLDL and oxHDL in obese prediabetic 
Latino adolescents, after controlling for changes in cardiorespiratory fitness. 
 
 
 
 
 
 
 
 
 
 
 
	   16 
CHAPTER 2. LITERATURE REVIEW 
 
2.1 Cardiovascular Risk Estimates in Latinos 
 Compared to other ethnicities, Latinos are at increased risk for CVD. In the most 
recent National Surveys, Latinos have shown elevated estimates of cardiometabolic risk 
factors. For instance, in 2016 Mexican-American adults (the most representative Latino 
group in the U.S.) had a higher prevalence of obesity, hypercholesterolemia, high blood 
pressure, as well as low PA levels.9,10 Not only physiological and behavioral risk factors 
are altered in Latinos, but their genetics also predispose them to certain cardiometabolic 
diseases. Latinos have shown single nuclear polymorphisms associated with T2D, 
rendering them genetically susceptible to this disease.12 Moreover, in the Hispanic 
Community Health Study/Study of Latinos, a substantial proportion of Latinos had a low-
cardiovascular (CV) risk profile, which is an ideal metric for preventing cardiometabolic 
diseases.11 Moreover, healthcare systems worldwide make tremendous efforts fighting 
CVD, but it seems that these efforts are not enough in communities with a high 
proportion of Latinos.18-20,136  
 Regarding children and adolescents, NHANES from 1999-2014 showed that 
among youth, those aged 12-19 y old had the highest prevalence of overweight (37.4%), 
and all classes of obesity. With respect to ethnicity, Latino adolescents showed the 
highest prevalence of overweight (41.8%) and class I and II obesity.32 Interestingly, in 
children from NHANES 1999-2012, mean values of most cardiometabolic variables were 
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higher as the severity of obesity was greater, with an exception for HDL in which mean 
values were lower as BMI increased.31  
 With respect to diabetes, in the 12-19 years group from NHANES 2005-2014, the 
weighted prevalence of combined T1D and T2D was 0.8%, and for prediabetes was 
17.7%, with almost one-third undiagnosed. Latino adolescents who were T2D 
undiagnosed (39.5% from all diabetic children) and prediabetic (22.9% from all diabetic 
children) were higher compared to non-Latino whites.36 Besides, in a recent study with 
individuals living in five regions of the U.S., the prevalence of diabetes significantly 
increased between years 2001 and 2009.35 In 2001, 0.34 per 1000 youth were diagnosed 
with T2D, while in 2009 the prevalence was 0.46 per 1000 youth. Considering ethnicity, 
in 2009 the prevalence of T2D was 0.79 per 1000 among Latino youth, with the greatest 
increase in the prevalence of T2D being from 2001 to 2009, compared to other ethnic 
groups.35 
 Other elevated estimates of cardiometabolic risk factors in Latino adolescents are 
a high prevalence of physical inactivity, with 20.3% of girls and 12.1% of boys reporting 
more inactivity, and 41.3% of Latinos who were less likely to meet the current aerobic 
physical activity (PA) guidelines. In regards to high blood pressure, from 2003 to 2013 
the death rate and the number of deaths increased 1.7% and 75.5% respectively, in Latino 
children.9 In NHANES from 1999-2008, among U.S. adolescents aged 12 to 19 y the 
overall prevalence was 14% for prehypertension/ hypertension, 22% for borderline-
high/high low-density lipoprotein cholesterol, and 6% for low high-density lipoprotein 
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cholesterol (<35 mg/dL), being Latinos the most contributing group to these high 
estimates.137 
 Therefore, Latino children are in substantial cardiometabolic risk because of the 
elevated prevalence of obesity, T2D, hypertension, and other associated conditions,31-33 
as well as the disparities in health-care that this ethnic group displays.34 These estimates 
make Latino adolescents an ethnic minority group with a high genetic, behavioral, and 
social risk for CVD. Due to these estimates, current Latino children and adolescents will 
probably account for most T2D and CVD cases as adults,37 with the consequent clinical 
and economic burden.138 
 
2.2 Defining Oxidative Stress 
 Oxidative stress results from an imbalance between oxidant production and 
antioxidant activity in cells and plasma. Thus, if any increased production of oxidants is 
present together with any antioxidant loss or dysfunction, oxidative stress is present.139 
Oxidants are substances that can undergo repetitive rounds of oxidation and reduction, 
and eventually yield to an increased production of superoxide anion radicals and 
secondary oxidants such as reactive oxygen species (ROS) or reactive nitrogen species 
(RNS).75,140 Within balance, ROS are primordial for physiological functions, including 
gene expression, cellular growth, infection defense, and modulation of endothelial 
function.126 However, overproduction of ROS and/or diminished antioxidant capacity can 
lead to dysfunctional oxidative stress. Besides ROS, free radicals (any chemical species 
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containing one or more unpaired electrons) and several no radical species are important 
oxidants as well.141 
 ROS and RNS have been implicated in atherogenesis within the vessel wall.51,74 
These oxidants can mainly originate from both cellular and extracellular sources, as well 
as from enzymatic and non-enzymatic pathways. Oxidant sources of physiological 
relevance are nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, xanthine 
oxidases, nitric oxide synthase (NOS), MPO, lipoxygenases, mitochondrial respiration, 
transition metals, and some others.76 MPO is of special importance since it can generate a 
series of secondary oxidation products with the ability to give rise to oxidized 
biomolecules, including oxLDL and oxHDL.142 
 
2.3 Insulin Resistance and Oxidative Stress as Common Pathogenic Factors for T2D 
and CVD 
 One of the common conditions present in T2D and CVD is insulin resistance.143 
Insulin resistance is an early condition which can lead to glucose dysregulation, impaired 
glucose tolerance (prediabetes), and finally to diabetes.144 Clinically, insulin resistance is 
defined as “the inability of a known quantity of exogenous or endogenous insulin to 
increase glucose uptake and utilization in an individual as much as it does in a normal 
population.”67 Insulin resistance is associated with an excess of caloric intake, lack of PA 
and obesity. In the insulin resistant state, compensatory hyperinsulinemia by pancreatic 
β-cells maintains normal levels of blood glucose. However, when β-cells are no longer 
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able to increase insulin production and compensate for insulin resistance, prediabetes 
appears. Persistence of all these conditions leads to frank diabetes. Moreover, obesity, 
insulin resistance, prediabetes, and overt diabetes, have been associated with an increased 
risk for CVD.145,146 
 The ”common soil” hypothesis postulates that T2DM and CVD also share 
common genetic and environmental antecedents.147 Evidence points towards oxidative 
stress generation as the common persistent pathogenic factor mediating T2DM and CVD, 
ultimately favoring atherosclerotic complications.148 The proposed mechanism relates 
oxidative stress with insulin resistance derived from excess in caloric intake and lack of 
PA. This surplus produces a substrate-induced increase in citric-acid cycle activity, 
generating an excess of mitochondrial NADH. The excess of NADH yields the 
consequent overproduction of free radicals, particularly superoxide anion radical, and 
ROS, leading to the implications of oxidative imbalance. In this context, insulin 
resistance may be seen as a compensatory mechanism protecting cells against additional 
insulin-stimulated caloric uptake. Moreover, in diabetes, the excessive production of 
oxidants is intensified by the low expression of antioxidant enzymes.77,78 
 The excess of caloric intake particularly affects pancreatic β-cells and endothelial 
cells, which leads to oxidative stress-related dysfunction. This effect is related to 
facilitated diffusion as the mechanism of these cells for glucose uptake since insulin-
regulated glucose transport is not present.149 Thus, when overfeeding, β-cells and 
endothelial cells cannot decrease the input of nutrients through insulin resistance, 
allowing intracellular concentration of ROS to increase further. Specifically, β-cells are 
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low in free-radical sequestering enzymes, making them susceptible to ROS, with the 
ultimate damage in insulin secretion.150,151 
 Studies suggest that elevated glucose and free fatty acid concentrations on β-cells 
induce mitochondrial production of ROS,152 inhibit essential cellular elements for first-
phase insulin production and suppress the insulin secretion through processes known as 
glucotoxicity and lipotoxicity.70 These processes are reversible at early stages; however, 
repeated exposure to hyperglycemia and high concentrations of free fatty acids can lead 
to irreversible β-cell dysfunction, causing fatal islet cell injury and accelerating β-cell 
loss. At this stage, both action and secretion of insulin is frankly impaired, accelerating 
the progression to T2D.71,72 Investigations have shown that oxidative stress induced by 
hyperglycemia is associated with the progression of diabetic complications, such as 
microvascular disease (diabetic retinopathy, nephropathy, and peripheral neuropathy), 
and macrovascular disease.76 
 
2.4 Oxidative Stress and Endothelial Dysfunction 
 Overproduction of mitochondrial superoxide anion radical through oxidative 
stress in the microvasculature is a subjacent characteristic of endothelial dysfunction. 
Increased oxidative stress in vulnerable tissues such as endothelium is exacerbated via 
activation of NADPH oxidase by the high activity of local renin-angiotensin 
systems.153,154 
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 In vitro, arteries from normal-glycemic animals exhibited attenuated endothelium-
dependent relaxation after been exposed to exogenous hyperglycemia.155 Furthermore, 
superoxide production was increased under hyperglycemic conditions in endothelial 
cells.156 In vivo and in cross-sectional studies with both diabetic and non-diabetic 
subjects, hyperglycemia also induced endothelial dysfunction.157 From all these studies it 
has been proposed that the hyperglycemic-overproduction of superoxide anion radical 
was the key component in the activation of pathways involved in the pathophysiology of 
endothelial dysfunction.  
 Another source of ROS in vascular cells is the overproduction of superoxide and 
hydrogen peroxide by endothelial nitric oxide synthase (eNOS), a pathway known as 
NOS uncoupling.158 The overproduction of superoxide anion radical is accompanied by a 
higher production of nitric oxide, favoring the generation of peroxynitrite, a potent 
oxidant that can cause DNA fragmentation and lipid peroxidation, ultimately resulting in 
acute endothelial dysfunction.79 Under all mentioned processes, excessive superoxide 
anion disrupts the balance between dilation and constriction. With this imbalance, the 
vasculature is prone to vasoconstriction, leading to lipoprotein oxidation, leukocyte 
adherence, inflammation, and some other diverse abnormalities, which are essential steps 
in atherosclerosis.80,81 
2.5 Atherosclerosis 
 Atherosclerosis is defined as a chronic, progressive, and multifactorial disease 
caused by complex and interrelated etiological factors that affect large and medium-sized 
arteries. It is characterized by the accumulation of fatty substances, cholesterol deposits, 
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inflammatory and chemotactic proteins, cellular waste products, calcium, and fibrin in the 
intima layer of arteries.43 
 High plasma LDL-c concentration has been the proposed factor that contributes to 
the initiation and progression of atherosclerosis.159-161 Interventions attempting to 
decrease LDL-c concentrations have shown reductions in CV events.162-164 In contrast, 
high plasma HDL-c concentrations have been traditionally associated with lower risk for 
atherosclerosis.165-167 However, studies focusing on HDL-c concentration have been 
controversial, since some studies have shown increased CVD risk at higher levels of 
HDL-c.168,169 Moreover, there have been interventions showing improvements on 
cardiometabolic, oxidative stress and inflammatory biomarkers despite that HDL-c levels 
decreased.170-172 Furthermore, other interventions that raised HDL-c did not have 
beneficial reductions in atherosclerosis.173 Current research is proposing indicators 
different than LDL-c and HDL-c concentration, such as lipoprotein particle size and 
number,174 as well as lipoprotein function,175 as better biomarkers associated with 
CVD.176-180 In this sense, evidence is pointing toward oxidized lipoprotein levels and 
lipoprotein dysfunction as measurement of oxidative stress, one of the main mechanisms 
associated with atherosclerosis.82,98,181,182 
 Three main hypotheses are proposed to explain how atherosclerosis begins: 
response to injury, response to retention, and oxidative modification hypotheses.51 
Among these hypotheses, the oxidative modification hypothesis represents the most 
convincing one; however, some authors agree that these hypotheses are all-inclusive.51,183 
The oxidative modification hypothesis describes how oxidative stress promotes 
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atherosclerosis. Within this hypothesis, the proposed essential mechanism explaining the 
role that ROS play in diabetes-induced endothelial dysfunction is the oxidation of 
lipoproteins, which are key elements inducing atherosclerosis.184,185 
 
2.6 Role of Lipoproteins in Atherosclerosis 
 A lipoprotein is defined as “a spherical particle that is used for the transfer of 
lipids and lipophilic substances in the circulation. It is composed of various amounts of 
phospholipids, cholesterol, and triglycerides as well as apoproteins.”45 Proteins and lipids 
in lipoproteins are at variable proportion, densities, and sizes. Main function of a 
lipoprotein is to transport water-insoluble lipids among cells and organs through the 
aqueous milieu (lymph and blood). There are traditionally five major classes of plasma 
lipoproteins, based on their buoyant density: chylomicrons, very low-density lipoproteins 
(VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), and 
high-density lipoproteins (HDL).44 Cholesterol and cholesteryl esters are packaged by 
enterocytes and hepatocytes into lipoproteins of different sizes and compositions that are 
further modified in the circulation. Lipoproteins are synthesized and catabolized in three 
distinct pathways: the chylomicron pathway, the VLDL/LDL/IDL pathway, and the HDL 
pathway, all of which are metabolically interrelated.46  
2.6.1 LDL and Oxidized LDL 
 According to the oxidative modification hypothesis, oxLDL plays a preponderant 
role in atherosclerosis initiation. The process starts when LDL particles (especially those 
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small and dense) traverse the sub-endothelial space of arterial sites that are susceptible to 
injury. During their trajectory, LDL particles are modified by oxidant enzymes, from 
which MPO has been mainly linked to this oxidation.101,142,186 Consequently, 
apolipoprotein and lipids within the LDL particles are oxidized,187 rendering them 
susceptible to macrophage uptake via scavenger receptor pathways.188 This results in the 
conversion of macrophages into cholesterol ester-laden foam cells189 that induce the 
synthesis of chemotactic proteins in smooth muscle and endothelial cells.190,191 As foam 
cells and chemotactic proteins accumulate, inflammatory cells are recruited.54,192 
Recruitment of inflammatory cells may result in continued macrophage internalization, 
LDL oxidation, and proliferation of smooth muscle cells.193 At this step, the 
atherosclerotic lesion begins and becomes the platform for catalytic extension of the 
lesion and the full-scale spectrum of atherosclerosis. 
2.6.2 HDL and Oxidized HDL 
 Regarding the role of HDL in atherosclerosis, its main beneficial effect is 
attributed to a mechanism called “reverse cholesterol transport,” in which HDL mediates 
the transfer of cholesterol from LDL, VLDL, and macrophages in the artery wall52,53 to 
be transported and degraded to the liver, and finally excreted into the bile. Originally, the 
concentration of cholesterol in HDL (HDL-c) was considered as the main biomarker 
associated with reverse cholesterol transport.194,195 However, recent findings suggest that 
HDL-c may not fully associate with CVD risk.196  
 Evidence showing that low HDL-c is not a strong predictor of CVD events comes 
from diverse epidemiological studies that have showed no association between HDL-c 
	   26 
and CVD events.197,198 Randomized control trials (RCT) using pharmacological increases 
of HDL-c have failed in reducing CVD risk. Drugs such as torcetrapib and dalcetrapib 
(cholesterol ester transfer protein inhibitors)173,199,200 and niacin,201 which raised HDL-c, 
have shown no reductions in CVD events or atherosclerosis. This evidence has directed 
the light toward HDL function as a better indicator of CVD risk.  
 Multiple beneficial functions have been associated with HDL particles, such as 
antioxidant, anti-inflammatory, antithrombotic, promotion of NO production, and 
protection from apoptosis.202 HDL particles have shown protection against LDL-induced 
cytotoxicity and LDL oxidation on endothelial cells.203,204 Experimental assays showed 
that HDL impaired the oxidation of LDL in endothelial and smooth muscle cell cultures, 
also impairing the expression of chemotactic factors.54 The favorable effects of HDL in 
atherosclerosis, such as cholesterol efflux, antiinflammation, and antioxidation, were 
mainly associated with small, dense HDL particles.55,56 These small particles are rich in 
antioxidant enzymes and antioxidant proteins such as paraoxonase-1 (PON-1), apoL-I 
and apoA-I.57 PON-1 in HDL has been associated with the prevention of lipid 
hydroperoxide accumulation on LDL.58 Furthermore, when HDL from normal subjects 
was tested on cultures of human aortic endothelial and smooth muscle cells, this 
lipoprotein prevented the oxidation of LDL and the induction of monocyte 
chemoattractant protein-1 (MCP-1).205 Besides, normal HDL containing the antioxidant 
enzymes platelet-activating factor acetylhydrolase and PON-1 prevented the formation of 
LDL-derived oxidized phospholipids.58,206 LDL from mice genetically susceptible to fatty 
streak lesion formation showed resistance to oxidation after being incubated with apoA-I. 
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Moreover, humans who were infused with apoA-I and human artery wall cells treated 
with this apoprotein showed resistance of LDL to cell-mediated oxidation.207 
 Conversely, when HDL is modified, it loses its function of removing cholesterol 
and becomes dysfunctional, exhibiting proatherogenic and proinflammatory 
properties.59,60,96 Particularly, HDL is vulnerable to modification by oxidants such as 
those generated by MPO, producing oxHDL.61,208 Experimental studies exploring HDL 
dysfunction showed that impaired effects in reverse transport were associated with apoA-
I oxidation by MPO. This apoA-I oxidation induced proliferation and migration of 
vascular smooth muscle cells, which represent one of the preliminary steps in 
atherosclerotic lesions.62  
  Likewise, when HDL from subjects with an acute phase reaction was used to 
inhibit the oxidation of LDL, it did not show any antioxidant activity, neither inhibition 
of monocyte chemotactic activity. This finding was associated with reduced activities of 
HDL-enzymes, which resulted in higher cell-mediated LDL oxidation and increased 
MCP-1 by the modified HDL during the acute phase reaction.209 Additionally, HDL 
obtained from coronary artery disease (CAD) normolipidemic patients was unsuccessful 
inhibiting LDL oxidation and MCP-1 generation. Conversely, HDL from sex-matched 
control participants inhibited these processes.210 Same results were obtained with HDL 
from patients with CHD, showing failed inhibition of LDL-induced MCP-1 
production.211 Moreover, HDL from T2D subjects showed diminished protective 
properties in endothelium, which suggested that diabetes mellitus is a condition that can 
	   28 
induce HDL dysfunction.212 Collectively, findings indicated that HDL from subjects with 
CVD and T2D was somehow defective preventing LDL oxidation. 
 
2.7 Myeloperoxidase-related Oxidation of Lipoproteins  
 MPO is a heme protein derived from leukocytes that is mostly found in 
neutrophils, monocytes, and macrophages. This enzyme uses H2O2 and chlorine anion to 
produce hypochlorous acid (HOCl) and further reactive oxidants, free radical species, and 
oxidant chlorinated molecules such as 3-chlorotyrosine, chlorohydrins, alpha-chloro fatty 
acid aldehydes, and tyrosyl radicals.213,214 Tyrosyl radicals have taken part in secondary 
oxidative reactions like the oxidation of LDL.215 Similarly, some other series of ancillary 
oxidation products by MPO like hydroxyl-amino acids, alpha-hydroxy and α,β-
unsaturated aldehydes216 can finally convert to the chemically well-characterized 
advanced glycation end product, NE-(carboxymethyl)lysine.217 There is 
immunohistochemical evidence of the presence of MPO/H2O2/halide system in human 
atherosclerotic lesions, in which colocalization of MPO and hypochlorite-modified 
proteins were found.218 All these molecules have the ability to generate oxidized 
biomolecules such as oxLDL and oxHDL.219,220  
 Elevated concentrations of chlorotyrosine and other oxidative byproducts were 
found in LDL obtained from human atherosclerotic lesions.221 Evidence suggested that 
MPO-generated hypochlorous acid was probably the initially responsible oxidant for both 
lipids and apo-B within LDL particles.222 Yang et al. (1999) showed that oxidation of 
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LDL by MPO in vitro produced selective modification of apoB-100.223 Similarly, Hazell 
et al. (1994) reported that oxidation of LDL by hypochlorite caused aggregation mediated 
by oxidation of lysine residues of apoB, without involving lipid peroxidation.224 
However, another research group (Heller et al., 2000) found that p-hydroxyphenyl-
acetaldehyde, an aldehyde generated by MPO, modified phospholipid amino groups of 
LDL in the human atherosclerotic intima.225 Together all data suggest that both 
modifications of lipids and apoB contributed to the production of oxLDL, which finally 
convert macrophages into foam cells.226 
 MPO-immunoreactive macrophages were found in human atherosclerotic plaques, 
within arteries and plaque rupture sites.227 Additionally, when activated MPO-containing 
macrophages were added to endothelial cells, cells were detached and dead. Likewise, 
hypochlorous acid added to endothelial cells induced apoptosis and release of tissue 
factor in a dose-dependent manner.228 Similarly, Steffen et al. (2006) found that 
cytotoxicity of MPO/nitrite-oxLDL toward endothelial cells was due to oxygenated 
cholesterols (oxysterols) formed during oxidation of LDL, specifically by a high 7 beta-
hydroxycholesterol to 7-ketocholesterol ratio.229 Data from the aforementioned studies 
suggests that MPO and metabolites derived from its activity play an important role in the 
activation and subsequent apoptosis of macrophages within arteries and endothelial cells.  
 Regarding HDL oxidation by MPO, when this enzyme is released in circulation 
and endothelial lesions, it binds to HDL at the helix 8-region of apoA-I. This binding is 
linked to the selective oxidative modification of apoA-I by the MPO-produced oxidants, 
showing increased concentrations of chlorotyrosine and nitrotyrosine.230 These 
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compounds are suggestive of protein contact with reactive chlorinating and nitrating 
oxidants produced by MPO.231,232 The oxidation of apoA-I is supposed to lead to 
functional impairment of HDL within the arterial wall, impeding the reverse cholesterol 
transport and promoting the initiation and development of plaque by these oxHDL 
particles.222 
 In a clinical investigation, subjects with greater concentrations of chlorotyrosine 
and nitrotyrosine within apoA-I had 16-fold, and 6-fold increased probabilities of having 
CVD, respectively.231 Increased levels of these oxidants within apoA-I are strongly 
associated with cholesterol efflux impairment.233 Moreover, elevated MPO-modification 
of apoA-I is linked to impairment of binding HDL to lecithin:cholesterol acyltransferase 
(LCAT), which is the enzyme responsible for converting free cholesterol into cholesteryl 
ester within HDL.234 Some other functional impairments of HDL due to the exposure to 
MPO or its oxidant products are a loss of anti-apoptotic and anti-inflammatory activities, 
specifically the diminishment of scavenger receptor–B1 (SR-B1) binding activity, as well 
as activation of nuclear factor-kB and expression of adhesion molecules.61 
 
2.8 Cross-sectional Studies Associating Oxidized Lipoproteins with CVD-related 
Outcomes 
 Several studies have associated oxidized lipoproteins with CVD risk factors 
and/or outcomes in youth. In regard to oxLDL, in ages as early as 3-5 years oxLDL levels 
(10.2±0.7 mg/mL) and lipid peroxides (6.8±0.5 mmol/mg protein) were significantly 
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higher in obese kids compared to control normal weight (7.2±0.7 mg/mL, and 4.2±0.2 
mmol/mg protein, respectively).235 Similarly, Kelly et al. (2010) analyzed oxLDL levels 
in normal weight and overweight/obese children from 6-18 y old. OxLDL levels were 
significantly elevated in overweight/obese children (69.1±14.1 U/L), compared to normal 
weight (56.6±12.4 U/L), and this biomarker was significantly correlated with adiposity 
and insulin resistance, independent of body fatness.100 Same research group reported 
oxLDL in extreme pediatric obesity, normal weight, and overweight/obese children from 
13.5±2.5 y old. Authors indicated that oxLDL increased significantly across BMI groups, 
concluding that extreme pediatric obesity was associated with increased concentrations of 
oxidative stress and inflammation.103 Likewise, in a previous study from our research 
group, Ryder et al. (2013) determined whether insulin resistance and abdominal adiposity 
were associated with elevated oxLDL in 123 Latino adolescents (16.3±2.5 y old). Levels 
of oxLDL were significantly different between groups (38.8±10.5 in lean vs. 44.7±13.9 
U/L in overweight/obese adolescents), and waist circumference and insulin sensitivity 
were significant predictors of oxLDL.99 
  With respect to relationships between oxLDL and CVD outcomes like carotid 
intima-media thickness (C-IMT) and flow-mediated dilation (FMD), obese children 
showed significantly higher levels of oxLDL (901.8±1128.9 ng/mL) than healthy 
children (279.5±270.5 ng/mL), with no significant correlation between oxLDL and 
carotid IMT.236 In another study, Jarvisalo et al. (2004) examined the correlates of nitrate-
mediated dilatation (NMD) including brachial artery endothelial function, oxLDL, and C-
IMT levels, in 142 children (age 8-17 y): 87 healthy, 41 with diabetes and 14 with 
familial hypercholesterolemia. NMD inversely correlated with oxLDL (r=-0.18, 
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p=0.045), and reduced endothelial function, increased oxidative stress, and preclinical 
carotid atherosclerosis were independent determinants of impaired NMD in this group.109 
Likewise, when metabolites of oxLDL such as MDA and conjugated diene (CDE) were 
analyzed from children of 16-18 y old with parents with premature myocardial infarction 
(MI), an increased susceptibility of LDL oxidation was found.237 
 Moreover, oxidative stress levels have been analyzed in a study performed by 
Stringer et al. (2009) in youth 12-15 y old from 3 groups: T2DM; age-, gender-, and BMI 
–matched (obese); and unmatched normal weight controls. Levels of oxLDL were 
significantly similar in T2D and obese, compared to normal weight control.108 Besides, 
Dasari et al. (2016) studied adolescents 13- to 21 y old with habitually low PA classified 
as healthy weight, healthy obese, or obese with T2D. OxLDL was higher (p<0.05) in 
T2DM (70.3±5.0 U/L) and healthy obese (58.1±3.8) than healthy weight (48.4±2) and 
positively correlated with mean amplitude of glycemic excursions (MAGE, r = 0.77).238 
 Other cross-sectional studies have been carried out using oxHDL as a biomarker 
of oxidative stress, although most of them are from the adult population. However, in a 
study with pediatric individuals by Marin et al. (2015), children aged 11-18 y were 
grouped as normal weight, obese, and obese+T2D. Biomarkers of oxidative stress were 
oxHDL, oxLDL, and MPO. OxHDL was 65% higher in the T2D group, whereas oxLDL 
was 23% and 56% higher in obese and in T2D, respectively, compared to normal weight. 
MPO was 88% elevated in T2D, compared to normal weight.107  
 Two studies from a longitudinal research regarding The Cardiovascular Risk in 
Young Finns Study showed significant findings with respect to oxHDL in adults. 
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Kaikkonen et al. (2016) determined levels of conjugated dienes in isolated HDL (oxHDL 
lipids) and LDL (oxLDL lipids) and their associations with future fatty liver in middle-
aged participants with normal liver (n=1286) and fatty liver (n=288). Subjects with 
elevated oxLDL lipids (odds ratio (OR)=1.27 for 1-SD change in oxLDL lipids, 
p=0.011), and with high oxidation score (oxLDL lipids + oxLDL protein, OR=1.34, 
p=0.012), had an elevated risk for fatty liver. The strongest direct association was seen 
with a high oxLDL lipids/oxHDL lipids ratio (OR=1.49, p=0.001).98 Likewise, in the 
same cohort, the associations of oxHDL lipids with atherosclerosis risk factors in 1395 
Finnish adults aged 24–39 y (54.9% women) suggested that advanced age was associated 
with lower oxHDL lipids levels. In men, lower oxHDL lipids were associated with 
elevated insulin levels, and in women with higher waist circumference and smoking. By 
contrast, higher CRP concentrations and alcohol intake were associated with higher 
oxHDL lipid levels.110  
 OxHDL levels were also analyzed in human obese adult females with metabolic 
syndrome grouped by BMI (17–25 and 30–40 kg/m2), without overt CVD. Participants 
with a BMI greater than 30 kg/m2 displayed higher levels of oxHDL and isoprostane (p< 
0.05), compared to BMI lower than 25 kg/m2. Higher levels of oxHDL were associated 
with greater concentrations of angiotensin II and the vasoconstrictor 20-
hydroxyeicosatetraenoic acid (20-HETE) (p< 0.05). Authors concluded that oxHDL 
represented a unique biomarker profile in obese females with metabolic syndrome at risk 
for developing CVD.97 
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As it can be observed in the aforementioned cross-sectional studies, research has 
shown a trend with higher levels of oxidized lipoproteins in overweight and obesity 
compared to normal weight, but also some studies have shown no significant differences 
between groups. Therefore, no consensus exists yet. Controversy in findings arises when 
chronic conditions are taken into account, such as prediabetes and T2D. Therefore, more 
research needs to be done to determine the relationships between lipoproteins and 
oxidative stress in metabolic conditions at early stages. 
 
2.9 Preventing Oxidative Stress through Diet and Physical Activity 
 The antioxidant defense system of an individual, which consists of the 
endogenous antioxidant enzymes and dietary antioxidants, can compensate oxidative 
stress. Numerous studies support the hypothesis that exercise-training and dietary intake 
of antioxidants alleviate oxidative stress.111,112 239 With respect to the endogenous 
enzymatic component enhanced by exercise, effects of interventions have been associated 
with a significant reduction in pro-oxidant parameters and an increase in enzymatic 
antioxidant capacity, regardless of intensity, volume, type of exercise, and studied 
population.125,126 Nevertheless, moderate to high-intensity exercise has proven to 
stimulate the endogenous antioxidant defense systems.127,128 
 Regarding dietary antioxidant nutrients, diets rich in fruit and vegetables, nuts, 
legumes, and whole grains, have reported exerting beneficial effects reducing CVD 
risk.240-244 Bioactive compounds such as soluble fiber, vitamins (vitamin A, vitamin E, 
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and vitamin C), phytochemicals (carotenoids, polyphenols, etc.), and minerals found in 
these foods act as antioxidants.245-249  The most likely proposed mechanism by which 
dietary antioxidant components reduce CVD has been decreasing ROS and their 
oxidative by-products. The antioxidants found in fruit and vegetables are associated with 
the scavenging of free radicals related to atherosclerosis,250,251 and with decreasing LDL 
susceptibility to oxidation.252-254 Furthermore, lipid-soluble vitamins and mono- and poly-
unsaturated fatty acids in grains,255 as well as protein, phytosterols, soluble and insoluble 
fibers in legumes,256 are all related to lowering-cholesterol effects, thus reducing CVD 
risk. With respect to whole grains, besides the antioxidant effects of its bioactive 
components, its reduced glycemic response has been proposed to decrease ROS 
generation.257 All these dietary antioxidants are especially important in at-risk population 
like obese and diabetics, in who oxidative stress is more likely to occur258,259 and 
antioxidant mechanisms are diminished.260,261 Multiple dietary antioxidants have been 
used for diabetics to ameliorate CVD complications. Compounds such as α-tocopherol, 
α-lipoate, and ascorbic acid supplementation have shown to be beneficial.262,263 
 
2.10 Behavioral Interventions Intended to Decrease Oxidative Stress 
2.10.1 Exercise Interventions 
 Although acute exercise induces an acute increase in ROS,264 exercise is one of 
the tested strategies that suggest long-term improvements of the endogenous enzymatic 
antioxidant capacity. In children and adolescents as well as adults, chronic exercise 
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induces beneficial adaptations of the endogenous enzymatic antioxidant defense.265 
Several studies in youth have shown positive effects on endogenous enzymatic activity, 
most of them exclusively applying aerobic and endurance exercise. With respect to 
regularly exercised population, oxidative stress levels after 23 weeks of swimming were 
evaluated in boys and girls of 10-11 y old, in which increased levels of reduced 
glutathione/oxidized glutathione ratio (GSH/GSSG) were observed.266 Similarly, long-
term exercise in team handball enhanced superoxide dismutase (SOD) activity; while 
aerobic capacity was positively associated with catalase activity, and negatively 
associated with hydroperoxide levels in participants of 16-19 y old.267 
 Considering overweight/obese children, a randomized trial with 112 participants 
7-11 y old compared to a no-exercise control group tested two different doses of exercise. 
Although reduced fatness and improved fitness were observed after the intervention, no 
effect of exercise was found on 8-isoprostane levels as a biomarker of oxidative stress.117 
Similar findings were observed by Kelly et al. (2007), who studied 19 overweight 
children randomly assigned to an aerobic exercise training or sedentary control group for 
8 weeks, and found no change in 8-isoprostane levels.135  
 With respect to oxLDL in exercise interventions, in a study carried out by 
Youssef et al. (2015), aerobic training for 12 weeks suppressed exercise-induced lipid 
peroxidation and inflammation in overweight/obese adolescent girls of 14-19 y old, 
compared to non-trained overweight/obese and the normal weight trained group.118 In 
contrast, Tjønna et al. (2009) studied two groups of overweight adolescents of 14.0±0.3 y 
randomized to either aerobic interval training or a multi-treatment approach. Authors 
found no significant changes in oxLDL in any group after 3 months of intervention.133 
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2.10.2 Dietary and Supplement Interventions 
 Regarding dietary antioxidants as a way to reduce oxidative stress in youth, 
studies have tested antioxidant-rich foods, supplementation, and caloric restriction.  
Among interventions using foods rich in antioxidants, the effect of 500 mL/day of pure 
(100%) mandarin juice (Citrus clementine) on biomarkers of oxidative stress in normal 
weight hypercholesterolemic children (8-12 y old) was tested during 28 days. After the 
intervention, plasma antioxidants vitamin E and C and intra-erythrocyte glutathione 
levels were significantly increased. Although antibodies to oxLDL remained unchanged, 
levels of MDA and carbonyl groups were significantly decreased, suggesting reductions 
in oxidative stress.268 Furthermore, the response to a commercial antioxidant supplement 
(a gummy-type candy) made from dried fruit, vegetable extracts, and added antioxidants, 
consumed twice a day for 21 days, was tested in healthy children aged 5-10 y, compared 
to placebo. Levels of breath pentane and urine 8-hydroxydeoxyguanosine, MDA, nitrites, 
and 8-isoprostane were not significantly different between groups, neither baseline or 
after intervention.269 
 With respect to supplementation, zinc was offered in a placebo-controlled 
crossover trial among 60 obese Iranian children (aged 6–10 y old). Participants were 
randomized into one of two groups; one group received 20 mg of elemental zinc and the 
other group received placebo, on a regular daily basis for 8 weeks. After a 4-week 
washout period, the groups were crossed over. In both groups and irrespective of the 
order of receiving zinc and placebo, significant decreases were found for Apo B/ApoA-I 
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ratio, oxLDL, leptin and MDA, total and LDL-c after receiving zinc, without significant 
change after receiving placebo.129 
 In regard to pediatric nonalcoholic fatty liver disease, a dietary intervention 
intended to decrease oxidative stress was evaluated using low-fructose diet versus low-fat 
diet in 10 children with NFLD (13.3±0.65 y) randomized to a 6-month pilot study. After 
the intervention, oxLDL was significantly decreased in the low-fructose group, but there 
was no change in the low-fat group.124  
 With respect to dietary caloric restriction, research with overweight/obese 
participants aged 7 to 15 y old aimed to analyze the impact of a 10-week diet-restricted 
intervention on oxidative status after weight loss (WL). After the intervention, subjects 
were dichotomized at the median of BMI-SDS change, as high (HR) and low responders 
(LR). Baseline serum TAC values in HR subjects did significantly predict the reduction 
in urinary F2 isoprostane after the program. Notably, changes in dietary TAC were 
associated with a decrease in body weight after the intervention in the HR group.113 In 
another study carried out by the same research group, obese children with mean age of 11 
years followed a 10-week weight loss program, in which they were also dichotomized as 
HR and LR after the intervention. The intervention consisted of moderate energy-
restricted diet, nutritional education, and family involvement. After the intervention, 
oxLDL significantly decreased in the HR group, and a positive correlation between 
changes in oxLDL and BMI-SDS was found.130 Similarly, in severely obese prepubertal 
children with mean age of 9.2±1.5 y compared to healthy normal weight subjects, a 6-mo 
dietary restriction-weight loss program normalized oxidant status, with significant 
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increases in lag phase and decreases in MDA. However, oxidative stress biomarkers 
returned to baseline levels after another 6 months of free diet.114 
2.10.3 Lifestyle-modification Interventions 
 Lifestyle interventions intended to diminish oxidative stress generally include the 
synergistic effects of exercise training and dietary modification. Roberts et al. (2007) 
examined overweight children (age 8–17) before and after a lifestyle modification 
intervention that consisted on a high-fiber, low-fat diet provided ad libitum and daily 
exercise (2–2.5 h) in a 2-week residential program. Significant reductions were noted in 
8-isoprostane, MPO, markers of endothelial dysfunction (sICAM-1, sE-selectin, CRP, 
MMP-9, and cellular MCP-1), as well as in superoxide and hydrogen peroxide in 
cultured, serum-stimulated human aortic endothelial cells.131 Likewise in a study 
performed by Li (2017), the effect of an exercise and dietary restriction intervention on 
oxidative stress was evaluated after 4 weeks in obese male adolescents aged 15.5±2.1 y 
old. The activities of the antioxidant SOD and glutathione peroxidase (GPx) enzymes 
were significantly increased, and protein carbonyls concentrations (PC) were reduced.132 
 Additionally, Kelishadi et al. (2008) applied a lifestyle intervention regarding 
aerobic PA with moderate to vigorous intensity 3 days/week and dietary advice for 6 
weeks, in obese children aged 12-18 y. After the intervention, oxidative stress biomarkers 
such as oxLDL and MDA significantly decreased and showed an inverse association with 
changes in mean FMD and a direct association with changes in mean C-IMT.119 
Furthermore, in a pilot study our research group reported significantly decreased 
concentrations of oxLDL and sE-selectin, compared to baseline, in 15 obese Latino 
	   40 
adolescents with a mean age of 15.0±1.0 y after a 12-week community-based lifestyle 
intervention focused on healthy diet and three 60-min sessions per week of PA.120 
 Similarly, lifestyle interventions have been applied using additional 
supplementation with antioxidants. A lifestyle modification program by Murer et al. 
(2014) with diet and exercise included daily antioxidants (vitamin E, 400 IU; vitamin C, 
500 mg; selenium, 50 mg) in overweight/obese children and adolescents (age 12.76 ±1.5 
y) in a 4-month fashion, where participants were randomly assigned to supplementation 
or placebo. There was a significant treatment effect of supplementation on antioxidant 
status measured by α-tocopherol, ascorbic acid, selenium, and oxidative stress measured 
by 8-isoprostane.115 Moreover, an intervention by D´Adamo et al. (2013) in obese 
prepubertal children aged 8.3±1.6 y with NAFLD has proven to be effective decreasing 
isoprostane as a biomarker of oxidative stress, as well as other cardiometabolic markers. 
The program consisted of a 6-month lifestyle intervention combined with vitamin E 
supplementation (600 mg/day), compared to age and sex-matched obese peers who 
underwent lifestyle intervention only.116 
 Changes in oxidative stress biomarkers have also been analyzed after other types 
of interventions, like bariatric surgery. In extreme obese adolescents with age lower than 
19 years who underwent Roux-en-Y gastric bypass (RYGB) or the vertical sleeve 
gastrectomy (VSG), Kelly et al. (2016) reported significant reductions after 12 months 
for interleukin-6 (IL-6), oxLDL and leptin, whereas adiponectin was significantly 
increased. Changes in these biomarkers did not differ by type of surgery.121 
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 Interventions focused on HDL dysfunction are limited. Regarding adults, the 
effects of a lifestyle intervention on the inflammatory/anti-inflammatory properties of 
HDL were examined in obese men (n =22). Participants were allocated to a 3-week 
residential program and provided with a high-fiber, low-fat diet ad libitum, and daily 
aerobic exercise. Lipid hydroperoxides and the HDL inflammatory/anti-inflammatory 
indexes were analyzed pre- and post-intervention, The HDL indexes were defined as the 
ability of serum-HDL to alter LDL-induced monocyte chemotactic activity (MCA) in a 
human artery wall co-culture. Findings showed significant decreases in lipid 
hydroperoxides, as well as in the HDL inflammatory index, with significant increases in 
HDL-anti-inflammatory index.171 Conversely, the effect of aerobic exercise for 6 months 
on lipid peroxide transport function of HDL was analyzed in a randomized controlled 
trial with sedentary women aged 43–63 y, compared to a control group. Authors reported 
that levels of oxHDL significantly increased 5% in the exercise group and decreased 2% 
in the control group. Additionally, the ratio of oxHDL/HDL-c increased by 5% in the 
exercise group and decreased by 1.5% in the control group, while CETP and adiponectin 
concentrations remained unchanged.270 
 In the pediatric population, two interventions are documented with HDL function 
as an outcome, while up to our knowledge no intervention has analyzed oxHDL levels. 
Wesnigk et al. (2016) reported the impact of a lifestyle intervention on HDL-mediated 
eNOS activation and HDL-reverse cholesterol transport in obese adolescents of 15±1 y 
old, who were randomized to a 10-month intervention group (restricted diet and exercise) 
or to a usual care group (UC). Anti-atherosclerotic HDL function and endothelial 
function improved, related to an increase in HDL-mediated eNOS-Ser1177 
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phosphorylation and to significant improvements in reverse cholesterol transport.134 
Besides, adolescent males with severe obesity and mean age 17.4±1.6 y were studied at 
baseline and 1 year after VSG bariatric surgery, compared to a lean group. The 
hypothesis was that atherogenic HDL profile (HDL subspecies and HDL function) would 
improve with metabolic surgery. Results indicated a reduction of 30% in HDL lipid 
peroxidation potential, significant increases in large apoE-rich HDL subspecies, 12% 
increased cholesterol efflux capacity, and 25% increased HDL anti-oxidative capacity.122 
 Findings respect to the effect of lifestyle interventions on youth regarding oxLDL 
and oxHDL are not conclusive. Most of the research has been done in overweight/obese 
population, but the effects of interventions on other metabolically ill population like 
prediabetics have not been analyzed. Moreover, no intervention has been done 
considering both oxLDL and oxHDL lipoproteins, which are specific early biomarkers of 
oxidative stress, as well as of atherosclerosis. This gap between the effects of 
interventions on oxidized lipoproteins and its application on young population at high-
risk needs to be reduced in order to prevent CVD at early stages. 
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CHAPTER 3. RESEARCH DESIGN AND METHODS 
 
3.1 Parent Study: Every Little Step Counts 
 This study is a secondary analysis from a recently completed randomized 
controlled trial (RCT) designed for preventing diabetes in youth: The Every Little Step 
Counts Study (ELSC). This parent study was a T2D prevention intervention for obese 
Latino adolescents, with the theoretical model in Figure 1 guiding the study. The ELSC 
study comprised 160 obese Latino adolescents aged 14–16 y to test the efficacy of a 
culturally-grounded, community-based lifestyle education intervention to improve insulin 
sensitivity and weight-specific quality of life in the short-term (3-month) and long-term 
(12-month).271,272 All participants (intervention and control) underwent testing at 
baseline, 3-months (post-intervention), 6-months (post-booster), and 12-months (9-
months post-intervention). Control youth were offered a modified version of the 
intervention upon completion.271,272  
 Briefly, adolescents at baseline were randomized to either the intensive lifestyle 
intervention or a control group. The intervention group consisted of one session weekly 
of nutrition education and three sessions weekly of exercise, during 12 weeks (3 months 
from baseline). During this period, the control group received health information 
materials and monthly phone calls, emails, or texts, according to their preference. The 
first follow-up was 3 months after the end of the intervention (6 months from baseline), 
in which the intervention group completed three monthly booster sessions following the 
intensive intervention period. These sessions were designed to support ongoing healthy 
lifestyle behaviors and address any challenges encountered in maintaining a healthy 
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lifestyle. During this first follow-up the control group continued having monthly phone 
calls, emails, and texts. The second follow-up was 9 months after the end of the 
intervention (12 months from baseline), in which both the intervention group and the 
control group had the same monthly phone calls, emails, or texts, to maintain contact, 
encourage participation, and avoid attrition during this period. The study design for the 
parent study is shown in Figure 2.  
 The Institutional Review Board at Arizona State University approved the study 
protocol and all study-related documents (Appendix A). The study was registered at 
www.clinicaltrials.gov (Clinicaltrials.gov Identifier: NCT01236794). Written parental 
consent (Appendix B) and child assent (Appendix C) were obtained by study staff prior 
to any data collection procedures. 
 
 
 
Figure 1. Theoretical model of the ELSC parent study.272 
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Figure 2. Study design of the ELSC parent study.272 
   
 
3.2 Recruitment  
 Participants were recruited through health organizations and centers partnering 
with ASU. Other organizations with the potential to recruit participants were community 
centers, churches, markets, etc., with predominantly Latino attendees. Study staff posted 
flyers including contact information from ASU, and also advertised in magazines, 
newspapers, and Internet media targeting the Latino population. Recruitment materials 
were in English and Spanish (Appendix D). 
 Youth and parents/guardians interested in the study contacted study staff and were 
informed about the intervention. Kids were asked to have an initial meeting for 
evaluation of eligibility, recruitment, and screening at the ASU Nutrition Laboratory. 
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During this initial meeting, participants were again informed about the lifestyle 
intervention, procedures, potential risks and benefits, and about the fact that they were 
free to withdraw at any time from the study. They were also informed that non-
participation would not affect them in any way and that confidentiality would be 
maintained throughout the study using an ID number in each material and test to identify 
each participant. After being informed about the entire study protocol, participants and 
parents willing to participate in the study provided written informed consent and were 
subjected to the screening evaluation. The evaluation was in fasting conditions (minimum 
of 10 hours) and participants were asked not to modify their regular lifestyle behaviors. 
 
3.3 Eligibility and Screening 
 Inclusion criteria were: a) age 14-16 y, b) being obese, measured through BMI 
percentile greater or equal to 95th for age and gender according to CDC growth charts, or 
BMI greater or equal to 30 kg/m2, and c) from Latino origin (parent-reported). For the 
secondary analysis in this dissertation, an extra inclusion criterion was: d) having 
increased risk for diabetes using an expanded definition of prediabetes according to the 
American Diabetes Association (ADA) criteria of either fasting glucose levels greater or 
equal to 100 mg/dL and/or a expanded definition of 2 hour glucose levels greater or equal 
to 120 mg/dL after a 75 g dose of an oral glucose tolerance test (OGTT). This last 
inclusion criterion ensured that any participant with prediabetes during the initial 
screening session was automatically assigned to the intervention group. This was justified 
given the rapid progression of T2D in youth with prediabetes and the ethical implications 
of randomizing a prediabetic kid to a control group.  
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 The exclusion criteria were: a) chronic or acute metabolic diseases, b) prior or 
current pregnancy, c) use of any medication that could influence carbohydrate 
metabolism, d) diagnosis of T1DM or T2DM, and e) participation in any other research 
program or activities related with health-improvements within previous 6 months. 
Participants detected with any health-related condition through the recruitment stage were 
referred to our partner clinic or their family doctor. 
 
3.4 Study Design 
 Youths with prediabetes at the parent study were not randomized and were 
assigned to the lifestyle intervention, being the study participants for this dissertation.  
Thus, this secondary data analysis followed a quasi-experimental design with pre- 
(baseline) and post-intervention (3-months) measurements.  
 
3.5 Sample Size and Effect Size 
 A convenience sample from the parent study was used in the secondary analysis 
to include only kids with prediabetes. The total sample size that made up the current 
secondary analysis was 35 participants. With this sample size and based on oxLDL as 
outcome for one sample t-test using a significance level of 0.05, with power =0.95, the 
calculated effect size was d=0.5675, which is considered a medium effect.  
 
3.6 Lifestyle and T2D-prevention Intervention  
 The 12-week lifestyle intervention was held at the YMCA as a partner institution. 
The lifestyle program curriculum was a culturally-grounded, community-based 
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intervention with community input into its development, design and implementation, and 
using “real-world” strategies for reaching vulnerable and underserved youth.272 The 
intervention consisted of the encouragement of social support and self-efficacy constructs 
within the Social Cognitive Theory (SCT).273 This theory considers that individual, social 
and environmental factors interact in a reciprocal manner to influence behavior. SCT 
constructs such as increasing self-efficacy, observational learning, goal setting, self-
monitoring, and fostering social support, were integrated into each intervention session. 
 Moreover, the overall program was based on an Expanded Eco-developmental 
model (Figure 3) and included multiple eco-developmental levels that influence 
individual health behaviors and health outcomes during the critical life period of 
adolescence. The levels of influence included in the intervention were social (family and 
friends), community, culture, and policy level factors.272 
The focus of the intervention was on obesity- and T2D-risk factors and health 
complications, healthy eating, family roles and responsibilities, PA and sedentary 
behaviors, and emotional well-being. The intervention included nutrition education and 
PA modules during 12 weeks and facilitators were partners from St. Vincent de Paul 
(nutrition module) and YMCA (PA module). Nutrition education consisted of one weekly 
session (60 min/session) delivered in a group setting by bilingual/bicultural certified 
“promotoras” (community health workers) from St. Vincent de Paul. The nutrition 
education sessions required the mandatory participation of at least one parent (or an adult 
relative) per kid. This module initiated with a discussion about their baseline lipid panel 
and glucose measurements found during screening. In the next sessions, healthy lifestyle 
choices were informed and behavioral strategies were implemented to improve health and 
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reducing T2D risk. Among topics were health awareness, roles and responsibilities, 
benefits of PA and exercise, reducing calories from sugar and fat, nutrition fact labels, the 
plate method,274 benefits from breakfast, reducing fast foods, and promoting healthy 
snacks. Participants practiced behavior change strategies275,276 such as goal setting, self-
monitoring, decision-making, and positive self-imaging, which were strategies 
established in the curriculum (Table 1). 
 
 
 
  
 
 
 
 
 
 
 
Figure 3. Conceptual framework of the ELSC parent study.272 
  
 The PA module consisted of three sessions per week (60 min/session) and 
included individual and group activities concerning structured aerobic and resistance 
exercise, and unstructured games. The focus of this module was on motor skill 
acquisition, exercise confidence, and developing a fitness base. A certified instructor 
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from YMCA conducted the PA sessions. Aerobic activities included running, spinning 
and cardio kickboxing, among others. Resistance activities included circuit training using 
age and size appropriate equipment. Some other activities were team sports, games, and 
activities promoting social support among youth. Heart rate monitoring and rate of 
perceived exertion were used to monitor and document exercise intensity throughout the 
program. Heart rate was monitored on a weekly basis with a target of 150 beats per 
minute. Participants were asked to complete at least 75% attendance from the 12-week 
lifestyle intervention.  
 
3.7 Outcome Measurements 
 Outcomes were measured at baseline and immediately after the intervention 
completion. Parents were asked to complete a family history questionnaire. Fasting blood 
samples were collected in order to measure lipid panel and biomarkers of oxidative stress. 
An oral glucose tolerance test (OGTT) was conducted to evaluate glucose and insulin 
concentrations, as well a HOMA-IR. Dietary intake of fresh F&V through a FFQ, as well 
as estimated VO2 peak by a cardiorespiratory fitness test (CRF) were measured as 
behavior variables.  
 
3.7.1 Family History Questionnaire  
 Parents were asked to complete a family history questionnaire (Appendix E).277 
Outcomes obtained from this were age, sex, country of family origin, country of birth, 
and family history of T2D, which were used to describe the sample. 
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Table 1. Overview of lifestyle education sessions in the ELSC parent study.272 
Session 1. Introduction  
Session 2. Understanding your health status 
Session 3. Healthy meal planning 
Session 4. Reducing sugar and fat intake 
Session 5. Increasing fiber intake 
Session 6. Eating breakfast 
Session 7. Appropriate portion sizes 
Session 8. Healthy snacking 
Session 9. Importance of physical activity 
Session 10. Enhancing self-efficacy 
Session 11. Enhancing self-esteem 
Session 12. Sustaining a healthy and balanced lifestyle 
 
 
 
3.7.2 Food Frequency Questionnaire 
 Dietary intake of fresh fruit and vegetables (F&V) was assessed using the Block 
Food Screener for Ages 2-17y version 2007 (Appendix F).278 This 41-item food 
questionnaire was adapted from the Block Kids 2004 FFQ, an 80-item questionnaire 
designed to assess food and nutrient intake in children ages 2-17 years. The food list for 
this screener was created using data from the NHANES 2001-2002 and 2003-2004, 
identifying the most important sources, appropriate portion sizes and nutrient 
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composition of each of the following food groups: whole grains, fruits, vegetables, 
potatoes, dairy, protein foods (meat, poultry, fish and legumes), high fat foods, and 
sweetened foods with added sugar. This screener has been used to evaluate dietary intake 
of kids from diverse ages and ethnicities, 279-282 although it appears more useful for 
adolescents.283 Recently, Hunsberger et al. examined the relative validity of this screener 
compared to three 24-h dietary recalls served as the reference, and no systematic 
difference between the two instruments were found for vegetable, dairy and 
meat/fish/poultry fat consumption. According to this validation study, this questionnaire 
is a useful dietary assessment instrument for the nutrients and food groups it was 
designed to assess in children age 10-17 years.284 
 The current version of this screener asks about food eaten "last week" in 
individual portion sizes (servings/day), with servings computed to g/d. The intake of 
fresh F&V as a composite variable was the main outcome, although individual foods 
were also reported. This screener took about 10-12 minutes to be self-completed by the 
participants.  
 
3.7.3 Anthropometry and Blood Pressure 
 Anthropometrics and sitting blood pressure were measured at baseline and after 
the intervention. Weight was recorded to the nearest 0.1 kg using a balance beam medical 
scale, and height and waist to the nearest 0.1 cm using a stadiometer and a tape measure. 
BMI was calculated as weight divided by height squared (kg/m2), and BMI percentiles 
were calculated based upon the Centers for Disease Control and Prevention 2000 growth 
charts (CDC, Atlanta, GA., USA). Sitting blood pressure was measured using an 
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appropriately-sized cuff on the right arm after the participant had rested quietly for 5 min 
using an Omron IntelliSense HEM-907XL automated blood pressure monitor (Omron 
Healthcare, Inc., Bannockburn, IL). 285 All measurements were done in triplicate and 
averaged. Body composition was estimated by bioelectrical impedance analysis using a 
Tanita Scale (TBF-300A, Tanita Corp of America, Arlington Heights, Illinois). 
 
3.7.4 Cardiorespiratory Fitness Test 
 Participants completed a single stage treadmill walking test, a submaximal aerobic 
fitness test, that estimated VO2max.286 Summarizing, resting heart rate (HR) from the 
participant was recorded and after been familiarized with equipment, the participant 
warmed-up on the treadmill selecting a comfortable speed at 0% grade that brings the HR 
to 50-70% of the HR max (recommended walking speed is from 3.4 to 4 mph).  At the 4-
min marker, the grade was increased by 5%, without changing the speed, and participant 
walked another 4 min. The steady-state HR (SS HR) was recorded from the average of 
the final 30 sec of the last two minutes at the 5% grade. Finally, the participant was asked 
to slow the speed and decrease the grade for 1-2 min cooldown (HR below 100 bpm). 
VO2max was calculated by the Ebbeling equation:286 
VO2max (mlŊkg-1Ŋmin-1) = 15.1 +21.8 (speed in mph) - 0.327 (SS HR in bpm) - 0.263 
(speed x age in years) + 0.00504 (SS HR in bpm x age in years) + 5.98 (gender; female = 
0, male = 1). 
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3.7.5 Cardiometabolic Risk Biomarkers: Lipid Panel and OGTT  
 Fasting-state blood samples (with at least 10 h overnight fast) were drawn at 
baseline and after intervention (within 24-48 hours of the last intervention session) from 
the antecubital vein to be collected into evacuated tubes as follows: one serum separating 
tube (10 mL), one EDTA-containing tube (4 mL), and one EDTA and glycolysis inhibitor 
(potassium oxalate and sodium fluoride) tube (4 mL). Blood was centrifuged at 3000 rpm 
at 5°C for 15 minutes, and serum/plasma was separated, aliquoted, and stored at -70°C 
for future analysis. The serum lipid panel was conducted by Sonora Quest Laboratory 
(Phoenix, AZ) and included total cholesterol, HDL-c, triglycerides, LDL-c (calculated), 
and non-HDL cholesterol (calculated). Total cholesterol and triglycerides were measured 
by photometric and HDL-c by homogenous enzyme immunoassay, using the 
corresponding colorimetric enzymatic reagents.285 Non-HDL-c was calculated as total 
cholesterol (TC) minus HDL-c. LDL-c was calculated using the Friedewald equation.287 
VLDL-c was estimated dividing the triglyceride value (mg/dL) by 5, according to Wilson 
et al.288 
 An OGTT was conducted in accordance with ADA. 289,290 Summarizing, blood 
samples were drawn in potassium oxalate and sodium fluoride EDTA tubes (4 mL) for 
glucose measurements and in EDTA tubes (4 mL) for insulin measurements at fasting 
conditions (-15 and -5 minutes before the dextrose solution, averaged). After that, 
participants consumed the dextrose solution (1.75 g/kg, with a maximum of 75 g) and 
venous samples were drawn 120 min after, to measure 2hour glucose and 2hour insulin. 
Fasting plasma glucose (FPG) and 2hour glucose were analyzed by the glucose oxidase 
method using the automated chemistry analyzer Cobas C111 (Roche Diagnostics, 
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Indianapolis, IN). Fasting insulin and 2hour insulin were measured by ELISA (ALPCO 
Diagnostics, Windham, NH). 
 Homeostasis model assessment of insulin resistance (HOMA-IR)291 was 
calculated using the following equation: 
HOMA = fasting glucose (mmol/L) x fasting insulin (µU/mL) / 22. 
 
3.7.6 Oxidative Stress Biomarkers: oxLDL and oxHDL 
 Oxidative stress biomarkers were measured in serum at baseline and after 
intervention using commercially available ELISA kits through sandwich enzyme 
immunoassay techniques. OxLDL was measured through a kit from Mercodia AB 
(Uppsala, Sweden) with the same specific murine monoclonal antibody mAb-4E6 as in 
the assay described by Holvoet et al.292 Mercodia Oxidized LDL ELISA is a solid phase 
two-site enzyme immunoassay that it is based on the direct sandwich technique in which 
two monoclonal antibodies are directed against separate antigenic determinants on the 
oxidized apolipoprotein B molecule. OxHDL was measured with an antibody specific for 
oxHDL with a kit from MyBioSource, Inc. (San Diego, CA.). This assay employs the 
quantitative sandwich enzyme immunoassay technique using antibodies specific for Ox-
HDL. The corresponding procedures were conducted according to each kit. 
 
3.8 Statistical Analyses 
 Untransformed outcome variables were expressed as mean (standard deviation, 
SD). For skewed variables, inverse or natural log transformations were calculated to meet 
the normality assumption. Variables that did not meet this assumption after 
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transformation (BMI percentile and dietary intake of apples, bananas and oranges) were 
analyzed by non-parametric Wilcoxon test. Changes in outcome measures for each 
participant were calculated subtracting baseline (pre) values from post values (post – pre), 
divided by baseline, and expressed as a percent. Changes were reported as mean (SD). 
For Specific Aims 1 and 2, differences between pre- and post-intervention outcomes were 
evaluated using Paired samples t-tests for unadjusted models. For Specific Aim 3, within-
subjects correlations were examined between changes in oxidative stress biomarkers and 
changes in fresh F&V dietary intake, after adjustment for changes in cardiorespiratory 
fitness. For this latter statistical analysis, the linear mixed models with maximum 
likelihood estimates were used to compute the correlation matrix and within-subject 
correlation coefficients, similar to partial correlation estimated by Bland and Altman 
(1995).293 All statistical analyses were performed using a p-value lower than 0.05 
(p<0.05) as significant, with SPSS 22.0 (IBM, Armonk, NY, USA) and SAS 9.4 (SAS 
Institute, Cary, NC) softwares. 
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CHAPTER 4. RESULTS  
 
4.1 Socio-demographic Characteristics  
 The sociodemographic characteristics of the study participants at baseline are 
shown in Table 2. A total of 35 Latino adolescents, mean age 15.5 (1.0) years and 51.4% 
male, participated in this intervention. A majority of participants identified themselves as 
Mexican (88.6%), and 77.1% were born in the U.S. Regarding family history of diabetes, 
43% had either mother and/or father history of T2D, and none of the participants had a 
diabetic sibling. 
 
4.2 Anthropometric Characteristics 
Participant anthropometric and physiologic characteristics at baseline and after the 
intervention are shown in Table 3. By design, BMI was greater than the 95th percentile at 
baseline, with a mean BMI percentile of 98.5 (1.2) and BMI of 35.0 (4.9) kg/m2. After 
the intervention, most anthropometric variables significantly decreased, such as weight (-
1.3% change, p=0.042), BMI and BMI percentile (-2.2% and -0.4% change, p=0.001, 
respectively), body fat (-6.6% change, p=0.025), and waist circumference (-1.8% change, 
p=0.025). Conversely, height (0.5% change, p<0.001) and VO2 max (7.0% change, 
p<0.001) significantly increased after the intervention. Regarding VO2max, 29 out of 32 
participants who completed both baseline and after intervention tests increased their 
VO2max (90%).  Systolic and diastolic blood pressure were comparable without 
significant change after the intervention (p>0.05).  
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Table 2. Socio-demographic and family history characteristics 
Variable All participants  
n=35 
Age in years, mean (SD) 15.5 (1.0) 
Sex, n (%) 
     Male 
     Female 
 
18 (51.4) 
17 (48.6) 
Country of family origin, n (%) 
     Mexican 
     Central American 
     South American 
 
31 (88.6) 
3 (8.6) 
1 (2.9) 
Born in U.S., n (%) 27 (77.1) 
Family history of T2DM, n (%) 15(43) 
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Table 3.  Anthropometric and physiologic characteristics at baseline and post-
intervention.a 
 
Variable Baseline Post % Change p valueb 
Weight (kg) 97.4 (16.7) 96.2 (17.3) -1.3 (3.3) 0.042 
Height (cm) 166.6 (8.2) 167.4 (8.6) 0.5 (0.5) <0.001 
BMI (kg/m2) 35.0 (4.9) 34.3 (4.9) -2.2 (2.8) <0.001 
BMI percentile 98.5 (1.2) 98.1 (1.9) -0.4 (0.8) 0.001c 
Body fat (%) 46.0 (7.9) 42.8 (6.8) -6.6 (8.8) 0.025 
Waist 
circumference (cm) 
110.2 (10.4) 108.1 (10.9) -1.8 (4.6) 0.025 
VO2 maxd 
(mlŊkg-1Ŋmin-1) 
29.7 (5.0) 31.6 (4.7) 7.0 (8.9) <0.001 
Systolic blood 
pressure (mm Hg) 
127.1 (16.5) 126.1 (10.9) 0.3 (11.5) 0.696 
Diastolic blood 
pressure (mm Hg) 
73.7 (9.3) 72.2 (7.0) -1.3 (9.4) 0.204 
 
a Data are shown as raw data, mean (SD). 
b Two-sided paired samples t-test. 
c Non-parametric Wilcoxon test. 
d n=32 
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4.3 Cardiometabolic Risk Biomarkers: Lipid Panel and OGTT Measurements 
 CVD risk biomarkers at baseline and after intervention are shown in Table 4. At 
baseline participants had fasting glucose levels of 85.6 (7.9) mg/dL, and per study design 
participants had prediabetes as measured by 2hour glucose levels after the OGTT (141.2 
(12.2) mg/dL). After the intervention mean changes for fasting and 2hour glucose levels 
were -0.3% (p=0.655) and -19.3% (p<0.001), respectively. Fasting insulin, 2hour insulin 
and HOMA-IR were significantly reduced by -12.9% (p=0.008), -53.5% (p<0.001), and -
12.5% (p=0.015), respectively. After the intervention, 23 participants (66%) reverted the 
IGT status toward normal glucose tolerance (NGT) according to the criteria of the 
Standards of Medical Care in Diabetes (2017) by the ADA.294 Concerning serum lipids, 
most variables were decreased after the intervention. Significant changes were found in 
triglycerides (-10.2% change, p=0.032), total cholesterol (-5.4% change, p=0.002), 
VLDL-c (-10.4% change, p=0.029), HDL-c (-3.2% change, p=0.022), and Non-HDL (-
5.5% change, p=0.0007). Although LDL-c also decreased after the intervention, it did not 
show statistical significance (-2.5% change, p=0.119).  
 According to the criteria of the Expert Panel on Integrated Guidelines for CVD in 
Children and Adolescents,295 mean triglycerides at baseline were considered high (151.2 
mg/dL), and the levels after intervention (129.3 mg/dL) reached borderline category of 
90-129 mg/dL. Total cholesterol both at baseline (155 mg/dL) and after intervention 
(145.8 mg/dL) were at acceptable levels of <170 mg/dL. In case of VLDL-c there are no 
guidelines for this lipoprotein, although this showed the greatest decreased according to 
the mean % of change (-10.4%, p=0.029). Regarding LDL-c, values at baseline and after 
intervention (85.5 and 82.3 mg/dL, respectively) were at the acceptable level of <110 
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mg/dL. In contrast, HDL-c at baseline was low (39.3 mg/dL) and even decreased after the 
intervention (37.7 mg/dL) keeping the low category of <40 mg/dL. Non-HDL levels both 
at baseline (115.7 mg/dL) and after intervention (108.2 mg/dL) were also at the 
acceptable level of < 120 mg/dL. 
 
Table 4. Cardiometabolic risk biomarkers at baseline and post-intervention.a 
 
Variable Baseline Post % Change p valueb 
Fasting Glucose (mg/dL) 85.6 (7.9) 85.1 (7.2) -0.3 (8.2) 0.655 
2hour Glucose  (mg/dL) 141.2 (12.2) 113.7 (30.5) -19.3 (21.5) <0.001 
Fasting Insulin (µU/mL) 33.5 (40.3) 27.6 (35.1) -12.9 (32.6) 0.008c 
2hour Insulin (µU/mL) 388.1 (164.9) 175.1 (139.6) -53.5 (32.8) <0.001d 
HOMA-IR 8.1 (9.9) 6.5 (8.3) -12.5 (34.3) 0.015c 
Triglycerides (mg/dL) 151.2 (74.1) 129.3 (68.2) -10.2 (27.6) 0.032d 
Total cholesterol (mg/dL) 155.0 (32.6) 145.8 (29.6) -5.4 (9.4) 0.002 
VLDL-c (mg/dL) 30.3 (14.8) 25.9 (13.6) -10.4 (27.5) 0.029d 
LDL-c (mg/dL) 85.5 (24.6) 82.3 (21.7) -2.5 (12.4) 0.119 
HDL (mg/dL) 39.3 (7.9) 37.7 (6.9) -3.2 (10.1) 0.022 
Non-HDL (mg/dL) 115.7 (32.2) 108.2 (28.0) -5.5 (11.7) 0.007 
 
a Data are shown as raw data, mean (SD). 
b Two-sided paired samples t-test. 
c P value using inverse-transformed data. 
d P value using log-transformed data. 
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4.4 Oxidative Stress Biomarkers: Oxidized Lipoproteins 
 Biomarkers of oxidative stress are shown in Table 5. According to the proposed 
hypothesis in Specific Aim 1, mean oxLDL was significantly decreased after the 
intervention (51.0 (14.0) U/L at baseline, and 48.7 (12.8) U/L after the intervention), with 
-3.5% of mean change (p=0.022). Conversely, results from oxHDL were contrary to the 
proposed hypothesis in Specific Aim 2, since oxHDL did not decrease after the 
intervention (p=0.944). In fact, mean oxHDL increased (395.2 (94.6) ng/mL at baseline, 
and 416.1 (98.4) ng/mL after intervention), with mean change of 8.3%. A decrease in 
oxLDL was observed in 20 participants (57%), and contrary to the hypothesis in Specific 
Aim 2, an increase in oxHDL was observed in 20 participants (57%). 
 
 
Table 5. Oxidative stress biomarkers at baseline and post-intervention.a 
 
Variable Baseline Post % Change p valueb 
OxLDL (U/L) 51.0 (14.0) 48.7 (12.8) -3.5 (11.5) 0.022c 
OxLDL/LDL-c 0.603 (.07) 0.599 (0.1) -0.4 (11.1) 0.356 
OxHDL (ng/mL) 395.2 (94.6) 416.1 (98.4) 8.3 (23.3) 0.944 
OxHDL/HDL-c 10.5 (3.6) 11.5 (3.9) 13.3 (28.9) 0.009 c 
 
a Data are shown as raw data, mean (SD). 
b Left-sided paired samples t-test. 
c P value using log-transformed data. 
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4.5 Dietary Intake of Fresh Fruit and Vegetables 
 Mean dietary intake of individual foods constituting our main outcome of fresh 
F&V (g/d), are shown in Table 6. For all the individual foods, mean intakes were non-
significantly increased after the intervention (all with p>0.05). Concerning our main 
outcome, mean dietary intake of fresh F&V were significantly increased (116.4 (97.0) g/d 
at baseline and 165.8 (91.0) g/d after the intervention, p=0.025), with 19 participants 
(54%) reporting increases after the intervention. 
 
Table 6. Dietary intake of fresh fruit and vegetables at baseline and post-intervention.a 
 
Food Baseline Post % Change p valueb 
Apple, bananas, and 
oranges (g/d) 
57.7 (59.8) 73.6 (58.1) 34.5 (108.6) 0.233c 
Any other fruit (g/d) 26.8 (32.1) 35.1 (38.1) 53.0 (215.7) 0.058d 
Lettuce salad (g/d) 14.4 (19.8) 25.1 (23.4) 37.3 (169.2) 0.481d 
Tomatoes (g/d) 3.3 (6.4) 6.2 (11.9) 104.2 (367.7) 0.426d 
Any other vegetable (g/d) 14.2 (18.2) 25.9 (22.6) 71.3 (204.9) 0.170d 
Total fresh F&V (g/d) 116.4 (97.0) 165.8 (91.0) 186.9 (409.8) 0.025 
 
a Data are shown as raw data, mean (SD). 
b Right-sided paired samples t-test.  
c Non-parametric Wilcoxon test. 
d P value using log-transformed data. 
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4.6 Correlations Between Oxidative Stress-related Biomarkers 
 The correlation coefficients with repeated observations were computed in within-
subject designs, using changes in oxLDL and changes in oxHDL as dependent variables 
respectively.  Each model used changes in fresh F&V intake as the dependent variable, 
and each was controlled for changes in VO2max. Table 7 shows the R coefficient for each 
correlation model, it can be noted that correlations were weak and no significant, with R 
coefficients for the correlation between oxLDL and Fresh F&V intake of R= -0.15 
(p=0.52), and for oxHDL and Fresh F&V intake of R= 0.22 (p=0.25). 
 
Table 7. Within-subjects correlation coefficients between changes in oxidative stress 
biomarkers and changes in fruit and vegetable intake. 
 
 Dependent 
variable 
Independent 
variable 
Covariate Correlation 
coefficient (R) 
p value 
Oxidized LDL Fresh F&V intake VO2max -0.15 0.52 
Oxidized HDL Fresh F&V intake VO2max 0.22 0.25 
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CHAPTER 5. DISCUSSION 
 
 Research regarding oxidative stress and CVD has been done in experimental 
models with cells, tissues, and animals.68,156,190,222,296 In cross-sectional studies the 
majority of information comes from the adult population.85,91,297 Efforts to reduce 
oxidative stress and CVD complications through dietary, supplement and/or exercise 
interventions have focused on adults298-301 and pediatric population such as overweight 
and obese.113,114,119,120 Few dietary and/or exercise interventions have been implemented 
among obese youth at high risk for CVD, such as children with liver steatosis,116 
NAFLD,302,303 hypercholesterole-mia,123 and metabolic syndrome,304,305 but children with 
prediabetes and or T2DM, up to current knowledge, have not been addressed. Practical 
lifestyle interventions that can be adapted and extended to daily life in prediabetic and 
T2D children, and focused on early oxidative stress biomarkers such as both oxLDL and 
oxHDL in a comprehensive manner and beyond current cardiometabolic biomarkers, up 
to current knowledge, have not been published yet.  
 Given the paucity of evidence regarding the effect of preventive interventions on 
lipoprotein oxidation in youth at high risk for cardiometabolic conditions, the present 
study was designed to evaluate the effects of a comprehensive T2D prevention 
intervention for obese prediabetic Latino adolescents on levels of oxidized lipoproteins as 
early biomarkers of oxidative stress. This is the first study specifically designed to test the 
effect of diet and PA modification on both oxLDL and oxHDL levels. Furthermore, this 
study adds to previous work by including measurements of behavioral variables such as 
changes in fresh F&V intake, as well as CRF (VO2max), as potential correlates in the 
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decreases of oxidized lipoproteins. The present study will be compared to interventions 
focused on oxidative-stress biomarkers using lifestyle modification in children. 
Interventions using variables different than oxLDL and oxHDL will also be discussed, 
since interventions are mainly focused on metabolites related to the oxidative process 
itself, such as isoprostane, MDA, etc. Some studies consider metabolites more directly 
associated with the atherosclerotic process, such as oxLDL, and even fewer have 
analyzed oxHDL.  
 
5.1 Anthropometric Outcomes and Oxidative Stress Biomarkers 
 Anthropometric variables are worth to report in interventions attempted to 
decrease cardiometabolic risk in children, even though their primary aim was not focused 
on anthropometry. It is important to analyze changes in CVD within the context of 
changes in anthropometry, to consider the contribution of the latter to the former. 
Moreover, evidence has been controversial showing CV health improvements when 
variables such as weight, waist circumference, BMI, and body fat are or are not decreased 
in obese children.306-308 
  The present study showed significant reductions in weight, BMI, total body fat, 
and waist circumference after the intervention (p<0.05), with significant decreases in 
oxLDL (p=0.022). Several lifestyle interventions have reported similar findings that are 
in agreement with the current study regarding decreases in oxLDL. Kelishadi et al. 
(2008)119 evaluated the effect of a 6-week lifestyle program among obese children, age 12 
to 18 y. This intervention was different in duration (6 weeks) than the present study, 
although the PA and dietary curriculum, as well as family participation, were similar. PA 
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sessions were 60 min, 3 days/week, and dietary advice was based on the optimized mixed 
diet, promoting the use of unrefined carbohydrate, dietary fiber from high-fiber whole 
grains, high intake of F&V, and restriction of hydrogenated fat.  Similar to the current 
study, results from Kelishadi et al. showed that BMI, waist circumference, and percent 
body fat were significantly decreased (p<0.05), together with significant decreases in 
oxLDL (p=0.02).  
 In a study by Li et al. (2017),132 oxidative stress biomarkers were evaluated with 
exercise coupled with dietary restriction through a 4-week program in 20 male obese 
adolescents. After the program, weight, BMI, lean body mass, body fat mass and fat mass 
ratio were significantly decreased (all p<0.05). Significant decreases in protein carbonyls, 
total glutathione, and total nitrites were observed, while activities of the antioxidant 
enzymes superoxide dismutase SOD and glutathione peroxidase were significantly 
increased. Although the same oxidative indicators were not measured, the present 
intervention also resulted in significant decreases in oxLDL. The study performed by Li 
et al.132 differed from the present study in terms of both PA and diet. Li et al. tested 
exercise training three times/day and 6 days/week during 4 weeks, with diets formulated 
by a dietician. Conversely, the current intervention had a longer duration (12 weeks) and 
lower intensity, and diet modification consisted of nutrition education. Despite the 
difference in the characteristics of the intervention, both studies showed decreases in 
anthropometry and oxidative biomarkers. 
 Some studies with intentional weight loss as part of the design have been 
reported. In a study carried out by Mohn et al. (2005)114 with severely obese Caucasian 
children (n=18; mean age 9.2±1.54 y; BMI >2 SD), a dietary restriction-weight loss 
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program was investigated in comparison with healthy Caucasian subjects matched for 
sex, age, and pubertal stage. Oxidant status normalized after 6 months in the intervention 
group (p=0.003), with similar levels than the control normal weight group. Changes in 
oxidant status were accompanied by decreases in BMI, waist-to-hip ratio, and fat mass 
(all p<0.05), but returned to baseline levels together with fatness indexes after 6 months 
of free diet. Even though the intervention from Mohn et al.114 differed from the current 
intervention in terms of the provided personalized hypocaloric diet and duration (6 
months), the main difference was the inclusion of a control group. In the present 
intervention it was ethically inappropriate to include a control group with prediabetic 
children since this condition is critical enough to automatically direct them to a 
preventive intervention.  
 In another study, Morell-Azanza et al. (2016)130 tested a 10-week weight loss 
program including a moderate energy-restricted diet, nutrition education, and family 
involvement in 40 obese children with mean age 11 y. Energy restriction varied among 
participants between 10% and 40% of total energy expenditure. After intervention 
participants were dichotomized at the median of BMI-SDS change as high (HR) and low 
responders (LR). OxLDL significantly decreased only in the HR group (p=0.028), 
however weight, the percentage of fat mass, waist circumference, and waist-to-hip ratio 
significantly decreased in both groups (p<0.05). By contrast, mean significant decreases 
in anthropometric outcomes and oxLDL were observed during the present intervention, 
without the need to divide the sample by the degree of BMI reduction.  
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Together, findings from the aforementioned trials and the present intervention 
allow inferring that decreases in oxidative stress biomarkers were coupled with weight 
loss and changes in body fat. Obese children have elevated levels of oxLDL than normal 
weight children,100,236 and higher oxLDL levels have been significantly associated with 
elevated BMI, body fat, visceral fat, and waist circumference.108,119 It has been proposed 
that adipose tissue up-regulates the overproduction of ROS due to the excessive caloric 
accumulation.309-311 These associations and the interventions reducing both fat mass and 
oxidative markers114,130,132 suggest that a greater fat mass determines a higher degree of 
oxidative stress, and that reducing adipose depots may result in decreases in oxidative 
stress. Therefore decreases in adipose tissue through weight loss might ameliorate the 
overproduction of oxidative stress biomarkers, as shown by the lower levels of oxLDL 
after this intervention.  
 Concerning randomized trials using only exercise, findings have been non-
conclusive.  Contrary to previous studies here discussed, no effect on isoprostane levels 
was found in a randomized trial using exercise with two different doses in 112 
overweight/obese children 7-11 y old.117 Lack of effect on isoprostane levels was 
observed despite reduced fatness (BMI, waist circumference, percent body fat, and 
visceral adipose tissue) and improved fitness (peak oxygen consumption VO2). Likewise, 
Youseff et al. (2015)312 aimed to determine whether aerobic training could reduce lipid 
peroxidation and inflammation. Classified as normal weight or overweight/obese, 39 
adolescent girls (14-19 y old) were randomly assigned to either a non-trained or trained 
group in a 12-week multivariate aerobic program. In normal weight girls, training 
prevented exercise-induced lipid peroxidation (p>0.05). Paradoxically, levels of oxLDL 
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were comparable in overweight/obese girls in trained and non-trained (p>0.05). These 
results suggested that the effect of exercise was only observed in normal weight girls. 
 Furthermore, no significant increases in oxLDL levels were reported after two 
treatments in a study carried out by Tjona et al. (2009),133 in which 54 overweight/obese 
adolescent girls (age, 14.0±0.3 y) participated. This intervention was a randomized trial 
to either aerobic interval training- AIT (twice a week for 3 months) or to a 
multidisciplinary approach- MTG (exercise, dietary and psychological advice, twice a 
month for 12 months). AIT was favorable compared to MTG in decreasing BMI, percent 
fat and mean arterial blood pressure (p<0.05). However, no significant increases in 
oxLDL levels after three months were reported for both treatments. Comparing both 
studies, the AIT program by Tjonna et al.133 and the present study had the same duration 
(3 months), although the present study found significant decreases in oxLDL and 
increases in oxHDL. 
 Likewise, Kelly et al. (2007)135 reported that in the absence of weight loss, 
exercise did not improve oxidative stress in 19 overweight children who were randomly 
assigned to an aerobic program or sedentary control group for 8 weeks. Although 
exercise improved VO2max, there were no differences between the intervention and the 
control group regarding changes in body weight or body composition, as well as for 
isoprostane levels (p>0.05). The study suggested that without weight loss, exercise might 
have little to no effect on oxidative stress. Contrary to the results from Kelly et al, in the 
present study both changes in anthropometric and oxidative biomarkers were observed. 
 In addition to aforementioned interventions, other studies have reported 
significant changes in oxidative stress biomarkers without changes in anthropometry, 
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which denoted that the former changes are not necessarily conditioned by changes in the 
anthropometric variables. In a prior pilot study, Ryder et al. (2014)120 examined the 
effects of the same intervention used in the present study in obese Latino youth (n=15, 
BMI percentile= 96.3±1.1%, 15.0±1.0 y). Relative to baseline data, the intervention 
resulted in lower oxLDL (- 21.8%, p= 0.001). When overall responsiveness to change 
was examined, oxLDL was reduced to 93.3%, with no significant changes in weight, 
waist circumference, and BMI. Findings differed from the present study in regards to 
anthropometric changes, in which the pilot study did not show changes, while the present 
study showed significant reductions in most anthropometric variables. It is important to 
mention that this pilot study included obese youth, while the current study included youth 
with prediabetes, a condition that represents hyperglycemia derived from a fail in the 
compensatory mechanism of insulin secretion. This difference in the severity of the 
condition may influence the difference observed in anthropometric changes comparing 
both studies.  
Findings from exercise training and PA promotion programs enable to suggest 
that exercise may induce different but related mechanisms to decrease oxidative stress, 
since some studies have shown lowering of oxidative stress biomarkers together with 
weight loss, and others despite no changes in weight and body fat. Results from the 
present study with changes in oxidized LDL as well as changes in anthropometry allow 
proposing that weight loss and exercise probably acted synergistically such that some of 
the beneficial effects of exercise might actually be exerted through decreases in body fat 
and/or changes in adipocyte function.135 It is documented that exercise reduces the 
secretion of inflammatory and oxidative molecules from adipocytes, as well as promotes 
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antioxidant enzymes action.125,127 Moreover, exercise can make the oxidative metabolism 
more efficient through improvements in cardiorespiratory fitness, which may lower the 
overproduction of ROS.312 Although the present intervention did not independently 
evaluate exercise, it was observed that oxLDL levels, weight, and body fatness decreased, 
and VO2 peak increased, after the exercise training and the nutrition education.  
 
5.2 Cardiometabolic Outcomes and Oxidative Stress Biomarkers 
The present intervention was successful in decreasing most of the cardiometabolic 
risk outcomes. Significant decreases were observed in 2hour glucose, fasting insulin, 
2hour insulin, and HOMA-IR. The effect on 2hour glucose after an OGTT, which is an 
indicator of the effectiveness of the intervention in preventing T2D, allowed reverting the 
prediabetic status in 66% of the sample. Besides, significant decreases were found in 
most of the lipid panel, with significant mean changes in triglycerides, total cholesterol, 
VLDL-c, HDL-c, and non-HDL-c (all p<0.05).  
 Concerning overweight/obese children, several studies have reported similar 
cardiometabolic improvements such as those shown in the present study. For instance, 
dietary modification is one of the common strategies to improve the oxidative status of 
individuals, and although not comparable to the nutrition education used in this 
intervention, both strategies have been useful improving cardiometabolic variables. For 
instance, the dietary modification was tested by Rendo-Urteaga et al. (2014)113 to 
investigate the potential health effects of dietary antioxidants consumed in mixed diets by 
measuring dietary and serum TAC, and urinary F2-isoprostane levels. The study 
evaluated the oxidative status of 44 overweight/obese children (mean age 11.5 y) after a 
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10-week weight loss program that consisted of prescribed fixed full-day meal diet, 
according to the individualized basal metabolic rate and PA levels. After the intervention, 
participants were dichotomized at the median of BMI-SDS change, as high (HR) and low 
responders (LR). Significant reductions were observed in fasting serum glucose, total 
cholesterol, insulin levels, and HOMA-IR in the HR group (p<0.05), as well as in 
anthropometric variables (p <0.001). However, opposite to the proposed hypothesis by 
Rendo-Urteaga et al., dietary TAC was reduced in both groups after intervention, with 
greater reductions in the HR group, and no significant associations between oxidative 
status markers and changes in adiposity and biochemical parameters.  
Concerning exercise, in a study performed by et al. (2005)313 the effect of 12 
weeks of aerobic exercise training (3 d/wk for 12 weeks, with 40 minutes each session) 
was examined in 19 overweight/obese girls (age 13.1±1.8 y; BMI 26.8±3.9 kg/m2). CRF 
and insulin sensitivity improved (p<0.05), without changes in body weight or percent 
body fat (p>0.05). The present intervention was different than Nassis et al.313 in 
anthropometric effects, but it was similar in improving insulin, as well as increasing 
VO2max (7.0%, p<0.001), albeit using different indicators.  
Similar findings were reported in the intervention by Tjonna et al. (2009)133 
aforementioned, where AIT induced a more favorable regulation of blood glucose and 
insulin than the MTG. After 3 months, greater decreases in 2hour glucose and insulin 
were observed in AIT compared to MTG. Overall, cardiometabolic changes demonstrated 
that aerobic training had a more robust influence on CV risk factors, compared to usual 
care. Participants that performed aerobic training had more robust physiological 
improvements than those participating in the MGT program by Tjonna. However, Tjonna 
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et al.133 reported no changes in oxLDL levels for both the AIT and the MGT programs, 
while in the present study significant decreases in oxLDL were found. 
 Bariatric surgery is among effective treatments for severely obese adolescents. 
Kelly et al. (2016)121 evaluated postsurgical changes in serum biomarkers in two cohorts 
of adolescents with severe obesity that had undergone elective bariatric surgery. 
Cardiometabolic outcomes such as glucose, insulin, and HOMA-IR were significantly 
decreased after 6 and 12 months (all with p<0.005, except for glucose in cohort 1 at 6 
months with p=0.233). OxLDL significantly decreased after 12 months (p= 0.03). These 
results were consistent with those obtained in the present intervention, in which levels of 
oxLDL and cardiometabolic variables were significantly decreased. The improvement on 
these biomarkers indicated that adolescents undergoing any of these interventions would 
potentially experience a meaningful decrease in cardiometabolic outcomes related to T2D 
and CVD risk. 
Improvements in early oxidative stress biomarkers such as oxLDL in the 
participants of this study were coupled with decreases in cardiometabolic variables such 
as insulin resistance and 2hour glucose, as well as triglycerides and VLDL-c. It has been 
proposed that the excess of caloric intake and lack of PA in obesity leads to the 
concomitant accumulation of ROS, which are suggested to induce inflammation,314 
insulin resistance, impaired insulin secretion,315 endothelial complications,316 and other 
metabolic disorders.143 Oxidative stress and systemic inflammation are closely related 
pathophysiological processes that are tightly linked with one another,317 since ROS can 
initiate the intracellular signaling cascades that enhance proinflammatory gene 
expression, and in turn inflammatory cells release ROS that lead to excessive oxidative 
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stress.318,319 Besides, ROS can induce systemic effects known as glucotoxicity and 
lipotoxicity, which also lead to impairment in insulin action and secretion.72,320 
Additionally, within the endothelium and under the oxidative modification hypothesis, 
the proposed initial step by which ROS induce the synthesis of chemotactic proteins and 
the recruitment of inflammatory cells is the oxidation of LDL.51,184,185 Findings from the 
present lifestyle intervention may suggest that the exercise training and the dietary 
modification here promoted leaded to decreases in ROS that resulted in lowering of 
oxLDL, with the consequent improvements in insulin resistance and hyperglycemia, as 
well as in lipids. These findings have important physiologic implications since 
prediabetic youth progress to T2D more rapidly than adults.321 Moreover, although not 
measured here, the suggested changes in oxidative species might also decrease 
inflammation, with the concomitant improvements in CV risk. Together, all findings lead 
to the recognition that the present intervention is an effective strategy to reduce oxidative 
and cardiometabolic biomarkers and to prevent the rapid progression of prediabetic youth 
toward T2D, thus decreasing CV risk. 
 
5.3 Outcomes Related to HDL Oxidation and Function 
 Studies concerning oxHDL in humans are scant, with most of the evidence 
coming from in vitro experimental studies from cells and tissues.322-324 This information, 
although it cannot totally be extrapolated to human studies, is useful when discussing 
HDL function and oxidation in the human population.    
 In vitro experimental studies with oxHDL and subspecies generated through 
oxidation are controversial since the evidence is divided, with some studies indicating 
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pro-atherogenic properties while others are showing anti-atherogenic properties. Respect 
to the pro-atherogenic properties, Matsunaga et al. (2003)322 determined that oxHDL 
activated nuclear factor-kB (NF-kB) during treatment of cultured human umbilical vein 
endothelial cells (HUVECs) with oxHDL. Activation of NF-kB was proposed to be via 
binding to oxLDL receptor-1 (LOX-1) on the cell surface followed by a significant dose-
dependent increase in intracellular ROS production, perpetuating the oxidative 
environment. NF-kB is suggested to be a vital signaling factor for negative vascular 
events such as endothelial apoptosis, ROS generation, and inflammatory responses.325  
Moreover, Soumyarani et al. (2014)323 quantified markers of oxidative stress, 
inflammation, and cytotoxicity in monocytes after treatment with oxHDL and oxLDL 
with the same range of MDA. Findings showed that similar to oxLDL (which was a 
positive control), oxHDL significantly induced oxidative stress, cytotoxicity, and release 
of TNF-alpha and MMP-9 in monocytes/macrophages, but with lower intensity than 
oxLDL. TNF-alpha is a well-recognized marker of systemic inflammation,326 and MMP-
9 is an enzyme that regulates pathological remodeling processes that involve 
inflammation and fibrosis in CVD.327 With respect to cellular apoptosis, in a study 
performed by Yao et al. (2017)324 oxHDL ingested by macrophages caused intracellular 
lipid accumulation and induced macrophage apoptosis with concomitant activation of the 
endoplasmic reticulum stress pathway, which resulted in increased inflammation.  
 Besides, Persegol et al. (2006)328 compared the ability of HDL from 16 T2D 
patients and 13 controls to suppress the inhibition of vasodilation induced by oxLDL 
using rabbit aorta rings. HDL from control subjects significantly reduced the inhibitory 
effect of oxLDL on vasodilatation, whereas HDL from T2D patients had no effect. HDL 
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triglyceride content was significantly higher in T2D patients than in control subjects. 
Similarly, Yao et al. reported that HDL from patients with metabolic syndrome induced 
macrophage apoptosis and oxidative stress.324 These studies showed that the ability of 
HDL to counteract the inhibition of endothelium-dependent vasorelaxation induced by 
oxLDL was impaired in metabolic syndrome and T2D patients, suggesting that HDL are 
less atheroprotective in metabolically impaired patients than in control subjects.  
 Conversely to the evidence of pro-atherogenic properties, there are also 
experimental studies proposing that oxHDL has anti-atherogenic properties. A study 
carried out by Girona et al. (1997)329 reported the effects of oxHDL subfractions 2 and 3 
(oxHDL2 and oxHDL3) compared to oxLDL and some products of oxidation 
(hydroperoxides and aldehydes), on the secretion of TNF-alpha from THP-1 human 
monocytes-derived macrophages in vitro. Inhibition of TNF-alpha by oxHDL2 (p<0.05), 
oxHDL3 (p<0.05) and oxLDL (p<0.05) from THP-1 macrophages was observed in the 
presence and absence of lipopolysaccharide. This inhibition was opposite of that reported 
by Soumyarani et al. (2014).323 Taking into account the differential effects showed on 
TNF-alpha, more research needs to be done to clarify the role of oxHDL in the inhibition 
or induction of secretion of inflammatory components such as TNF-alpha. 
 Additionally, Zhou et al. (2017)330 determined the effects of MPO-modified 
oxHDL (nitrated and chlorinated oxHDL) on smooth muscle cell (SMC) migration and 
atherosclerotic plaque stability in vivo using a carotid artery collar implantation mice 
model.	  Native HDL promoted SMC proliferation and migration, whereas nitrated oxHDL 
and chlorinated oxHDL inhibited SMC migration and reduced capacity of stimulating 
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SMC proliferation as well as migration, respectively, with no significant influence of 
oxHDL on SMC apoptosis. 
Some metabolites from oxidative modifications of HDL, such as tyrosyl radical-
oxHDL (tyrHDL) by MPO, have increased the availability of cellular lipids for apo-
mediated HDL particle formation. These metabolites would be expected to increase total 
reverse cholesterol transport and decrease the development of atherosclerosis.331 In a 
series of studies, Francis et al. showed that tyrHDL markedly enhanced depletion of the 
regulatory pool of cell cholesterol available for esterification by acyl-CoA:cholesterol 
acyltransferase (ACAT), compared to native HDL, in cultured human fibroblasts, mouse 
peritoneal macrophages, and human arterial smooth muscle cells.332 In another study, the 
same research group found a marked increase in efflux to apoAI after incubation of 
fibroblasts with tyrHDL.333  
In line with same previous research, Wang (1998)334 investigated the structural 
modifications in tyrHDL, in which apoAI-apoAII monomer and apoAI-(apoAII)2 
heterodimers showed a markedly increased ability to prevent the accumulation of LDL-
derived cholesterol by sterol-depleted fibroblasts, compared to other apolipoprotein 
species of tyrHDL. These results indicated a novel product of HDL oxidation, apoAI- 
apoAII heterodimers within tyrHDL, with a markedly enhanced capacity to deplete cells 
of the regulatory pool of free cholesterol and total cholesterol mass. Moreover, 
Macdonald et al. (2003)335 injected 150 µg of tyrHDL intraperitoneally twice weekly in 
apoE-deficient mice. A maximum 2.3-fold increase in endogenous HDL cholesterol 
levels was observed, and tyrHDL treatment showed 37% less aortic lesion development 
than control HDL-treated mice (p<0.001). This study demonstrated that treatment with 
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tyrHDL raised endogenous HDL-c levels and decreased atherosclerosis development in 
apoE-deficient mice.  
 In regard to the degree of oxidation, Gao et al. (2008)336 analyzed the effects of 
copper and hypochlorite (that preferentially oxidize lipids and proteins, respectively) on 
thermal stability of plasma spherical HDL. The study showed that mild oxidation 
destabilized HDL and accelerated protein dissociation and lipoprotein fusion, lowering 
kinetic barriers for HDL remodeling. In contrast, advanced oxidation inhibited protein 
dissociation and HDL fusion. Gao et al. concluded that mild oxidation of HDL promoted 
remodeling of human HDL in vitro, which may benefit HDL functions, while advanced 
oxidation impaired it. These findings helped to clarify the apparent controversy regarding 
structural modifications of oxHDL that promote HDL remodeling. 
 In addition, Valiyaveettil et al. (2008)337 reported that oxHDL, but not native 
HDL, was a potent inhibitor of platelet activation and aggregation induced by physiologic 
agonists. This effect was especially important since activated platelets and platelet extra-
cellular vesicle (PL-EV) release are essential factors in atherosclerosis, promoting 
thrombosis and plaque formation.338 The anti-thrombotic effect was concentration- and 
time-dependent and positively correlated with the degree of lipoprotein oxidation. 
Similarly, an in vitro study carried out by Tafelmeier et al. (2017)339 focused on the effect 
of mildly oxHDL and native HDL on platelet aggregation and PL-EV release. Mildly 
oxHDL significantly decreased PL-EV release by -36% and partially reversed agonist-
induced platelet aggregation, in comparison to native HDL. In addition, mildly oxHDL 
improved platelet membrane lipid homeostasis through increased uptake of 
lysophospholipids and their remodeling to corresponding phospholipid species. 
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Furthermore, Talens et al. (2013)340 investigated the possible function of oxHDL in 
coagulation and fibrinolysis by thromboelastography. Addition of oxHDL resulted in 
reduced clot firmness in a time-dependent effect, while oxLDL and native HDL did not 
show any effect. The effect was correlated with a shift in the apolipoprotein AI protein 
band around 25 kDa. These studies support the notion that mildly oxHDL has inhibitory 
abilities on platelet activation and aggregation, as well as beneficial effects on 
coagulation and fibrinolysis, which represent anti-atherosclerotic properties. 
 The experimental evidence here discussed suggests that oxHDL elicits different 
anti- and pro-atherogenic properties, which depend on factors like the cell lines used 
(human or animal) during in vitro studies, the time of exposure and dose of oxHDL on 
assays, but mainly on the degree of oxidation of HDL. Most of the research from mildly 
oxHDL previously mentioned established beneficial effects on remodeling HDL reverse 
cholesterol transport, cholesterol efflux, platelet aggregation and release of pro-coagulant 
platelet extracellular vesicles, as well as coagulation and fibrinolysis. The increases in 
oxHDL levels after the lifestyle intervention, although non-significant, might indicate the 
possibility that oxHDL has antiatherogenic properties. It would be interesting to elucidate 
the degree of oxidation in HDL from participants after the current intervention, as well as 
some other chemical characteristics of oxHDL particles that could lead to the mechanism 
by which oxHDL influence the risk of CV.  
 There are few cross-sectional human studies regarding HDL function and 
oxidation. Concerning oxidation, Peterson et al. (2016)97 compared levels of oxHDL 
between lean and obese adult females with no CVD (total n=16). Obese patients showed 
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6-fold higher levels of oxHDL compared to normal weight, as well as higher 
oxHDL/total HDL ratio as BMI was higher.97 In youth, similar results were reported by 
Marin et al. (2015),107 who analyzed levels of both oxLDL and oxHDL in 37 normal 
weight, 38 obese, and 42 obese T2D adolescents, aged 11–18 y. Greater concentrations of 
oxHDL were reported in obese T2D children (65%), and oxHDL was not correlated with 
insulin resistance (HOMA-IR), while it was positively associated with oxLDL and lean 
body mass. Based on these studies that showed greater levels of oxHDL in obese 
compared to normal weight, it was hypothesized that oxHDL levels would decrease after 
the present intervention. However, contrary to the hypothesis, oxHDL levels increased 
yet not significant. 
 Two cross-sectional investigations from The Young Finns Study have been 
documented. Kresanov et al. (2013)110 investigated the associations of oxHDL lipids 
(based on conjugated dienes) with known risk factors for atherosclerosis in 1395 Finnish 
adults ages 24-39 y (54.9% women). A significant inverse association was found between 
oxHDL and age, and a direct association with oxLDL lipids after adjustment for Apo-A1. 
Additionally, in men oxHDL lipids were inversely associated with insulin. In women, 
oxHDL lipids were inversely associated with waist circumference and daily smoking, and 
directly with CRP and alcohol use. The study carried out by Kresanov et al. allowed to 
conclude that an elevated risk profile characterized primarily by advanced age was 
associated with lower oxHDL lipid levels in this sample. In parallel with these studies, 
lower levels of oxHDL in the present sample were detected at baseline, compared to 
increases observed in oxHDL levels after intervention and improvements in 
cardiometabolic outcomes. Results from the present study were consistent with those 
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reported by Kresanov et al.,110 although not totally comparable because of the nature of 
each study (cross-sectional vs. interventional). 
 Another study from the aforementioned group and published by Kaikkonen et al. 
(2016),98 determined circulating levels of oxidized lipids in LDL and HDL (through 
conjugated dienes and a method based on antibodies against oxLDL) and their 
associations with fatty liver, in 1286 middle-aged participants with normal liver and 288 
with fatty liver. Lower significant levels of oxHDL were reported as the degree of 
severity of fatty liver increased, Moreover, participants with elevated oxLDL lipids had 
an increased risk for fatty liver (p=0.011), and a high oxidation score 
(oxLDLlipids  +  oxLDLprot) was directly associated with fatty liver (p=0.012). These 
data indicated that oxLDL lipids were directly linked with risk of fatty liver in middle-
aged adults, while oxHDL levels were inversely linked to the severity of the disease. 
Findings from The Young Finns Study agreed with results from the present study 
regarding levels of oxHDL related to CVD risk. It might be that compensatory 
mechanisms attempting to reduce CV risk provoke increases in oxHDL after the 
intervention here presented, such as higher rates of remodeling HDL, reverse cholesterol 
transport, and cholesterol efflux, in an attempt to prevent and decrease the accumulation 
of oxidized lipids and other oxidants. All these aspects could explain why oxHDL levels 
were lower at baseline and increased after the intervention. 
 The number of interventional studies regarding HDL function and/or oxidation is 
limited. Among them, Roberts et al. (2006)171 examined the effects of a lifestyle 
intervention in obese men (n =22) allocated to a 3-week residential program providing a 
high-fiber, low-fat diet ad libitum, and daily aerobic exercise. Lipid hydroperoxides and 
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the HDL inflammatory/anti-inflammatory indexes were measured pre- and post-
intervention. Significant decreases in lipid hydroperoxides were shown, as well as in the 
HDL inflammatory index, with significant increases in HDL-anti-inflammatory index.  
Moreover, in a randomized controlled trial with sedentary women aged 43–63 y, the 
effect of 6-month aerobic exercise on lipid peroxide transport function of HDL was 
analyzed by Tiainen et al. (2016),270 compared to a control group. Similar to increases 
found in the present intervention, both the levels of oxHDL and the ratio of 
oxHDL/HDL-c significantly increased 5% in the exercise group, and decreased 2% and 
1.5% respectively, in the control group, while CETP concentrations remained unchanged, 
implicating that the transfer of cholesteryl esters and triglycerides between lipoproteins 
remained stable. Findings from the current study were similar to the elevation in oxHDL 
after the intervention by Tiainen, in which the present intervention resulted in 8.3% 
increases in oxHDL levels (p=0.056) and 13.3% of oxHDL/HDL-c ratio (p=0.009) were 
found after the intervention.  
 In athletes, Valimaki et al. (2016)341 examined the effects of endogenous 
oxidative stress induced by acute exhaustive physical exercise on the concentration of 
oxHDL lipids in 24 male national top-level endurance runners who performed a maximal 
run on a treadmill until exhaustion. Immediately after the treadmill run, the concentration 
of oxHDL lipids and the ratio of oxHDL lipids/oxLDL lipids increased by 24 % (p<0.01) 
and 55 % (p<0.001), respectively, while oxLDL lipids levels decreased by 19 % 
(p<0.001). Simultaneously, MDA and serum total peroxyl radical trapping antioxidant 
potential (TRAP) increased by 54% (p < 0.001) and 29% (p<0.01), respectively. After the 
90 min recovery, the concentration of oxHDL lipids decreased towards the pre-exercise 
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level, but oxLDL lipids remained decreased below pre-exercise values (p<0.001). 
Although with different participant characteristics, current outcomes in the present study 
partially agreed with increases in oxHDL after exercise by Valimaki et al., suggesting 
that during physical exercise, HDL has an active role in the removal of lipid peroxides, 
showing elevated concentrations compared to baseline.  
 Respect to dietary modification, a randomized controlled trial by Hernáez et al. 
(2017)342 assessed the effects of traditional Mediterranean diet (TMD) on HDL function 
in a random subsample of 296 adult volunteers from the PREDIMED Study, after one 
year of intervention. Two variations of the diet were compared: one enriched with virgin 
olive oil (TMD-VOO; n=100) and the other enriched with nuts (TMD-Nuts; n=100), 
compared to a low-fat control diet (n=96). Both diets significantly increased cholesterol 
efflux capacity relative to baseline (p<0.05). The TMD-VOO intervention decreased 
CETP activity (p=0.028) and increased HDL ability to esterify cholesterol, paraoxonase-1 
arylesterase activity, and HDL vasodilatory capacity (all p<0.05). Adherence to the 
Mediterranean diet, especially when enriched with virgin olive oil, was associated with 
increases in the key HDL functions here analyzed. Intervention by Hernáez et al. 
improved HDL function through an antioxidant-rich dietary pattern such as the traditional 
Mediterranean diet, which promotes frequent intake of fresh F&V. 
 In pediatric interventions, outcomes were mainly concerning HDL function and 
particle size. Albeit difficult to directly compare these interventions with the present 
study, these studies can be used to highlight the effect of interventions on HDL function. 
In a randomized trial Wesnigk et al. (2016)134 analyzed the effect of a 10-month lifestyle 
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intervention on HDL-mediated eNOS activation and HDL-reverse cholesterol transport 
with either intervention group (restricted diet and exercise) or usual care group (UC) in 
obese adolescents of 15±1 y old. The HDL-mediated phosphorylation at position Ser1177 
of eNOS and the efflux capacity of HDL significantly increased after the intervention 
(p<0.05), both important factors involved in reverse cholesterol transport, while the UC 
group showed no difference in phosphorylation of eNOS (p= 0.08) and a significant 
decline in efflux HDL capacity (p=0.05). Additionally, the lifestyle intervention resulted 
in reductions in BMI and body fat (p< 0.001), with a 10% increase in maximal oxygen 
uptake (p=0.002), while the UC group did not show changes. This study denotes the 
importance of promoting a restricted diet and exercise in obese adolescents to improve 
HDL function. 
 Moreover, a study carried out by Davidson et al. (2017)122 tested the hypothesis 
that atherogenic HDL profile (HDL subspecies and HDL function) would improve with 
VSG bariatric surgery in adolescent males with severe obesity (mean age 17.4±1.6 y). 
Outcomes were analyzed at baseline and after 1 year, compared to a lean group of 
adolescents. Decreases in HDL lipid peroxidation potential by 30%, and significant 
increases in large apoE-rich HDL subspecies, as well as 12% increased in cholesterol 
efflux capacity and 25% increased in HDL anti-oxidative capacity were found.122 
Considering both pediatric interventions by Wesnigk and Davidson et al., as well as the 
present study, benefits related to HDL function and oxHDL levels were found with 
improvements in anthropometric and cardiometabolic outcomes, despite participants kept 
obese after the intervention. Future research must focus on elucidating the effects of 
lifestyle modification on the function, structure, and composition of oxHDL. Outcomes 
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such as changes in the degree of oxidation and function, as well as structural 
modifications and some other important lipoprotein characteristics must be taken into 
account during future T2D prevention interventions. Differences in atherogenic 
properties have been observed depending on the chemical characteristics of oxHDL. 
HDL that is mildly oxidized have exerted beneficial effects regarding HDL reverse 
cholesterol transport, cholesterol efflux, decreasing platelet aggregation and release of 
pro-coagulant platelet extracellular vesicles, as well as coagulation and 
fibrinolysis.332,333,336,337 Detecting these modifications on oxidized lipoproteins will allow 
understanding physiologically and chemically how lifestyle modification can reduce 
atherosclerotic risk at early stages. 
 
5.4 Changes in Fresh Fruit and Vegetable Intake and its Correlation with Changes 
in Oxidized Lipoproteins 
In the present study, dietary intake of fresh F&V was significantly increased, with 
values of 116.4 (97.0) g/d at baseline and 165.8 (91.0) g/d after the intervention, p=0.025. 
It was interesting to observe that although each component of this dietary composite 
outcome increased after the intervention, individual food changes were non-significant 
(p>0.05, Table 5). Weak and non-significant within-subjects correlations were detected 
between changes in oxLDL and fresh F&V intake (R=-0.15, p=0.52), and between 
changes in oxHDL and fresh F&V intake (R=0.22, p=0.25), both adjusted for VO2max 
changes (Table 7).  
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 It is worth discussing here that studies regarding dietary assessment have found 
that children and adolescents are prone to report errors during dietary intake records and 
questionnaires at both group and individual level, with the existence of subject-specific 
responding in dietary assessments 343 Most of the errors were related to under-reporting, 
since dietary reports are influenced by body weight status, especially in obese children 
like participants in this study. Furthermore, this error does not occur systematically across 
different age groups or different dietary survey techniques.344 Nevertheless, it is 
important to note that even with the possibility that under-report could occur, significant 
increases in fresh F&V intake as a whole food group were detected.  
 The dietary modification has been one of the most extensive recommendations for 
CVD prevention. Diverse nutrients in F&V have been associated with lower risk for 
CVD; however, it is important to consider fresh F&V as a whole food group due to its 
physical and biochemical complexity and the interaction between their nutrients.242 In 
recent years diet-based approaches have been more effective in reducing CV risk than 
single nutrient-approaches.345,346 Intake of F&V in adults has been associated with a 
reduced rate of developing CVD, such as CHD and stroke.347 There is scientific evidence 
in both adults and children that show that dietary patterns characterized by a high intake 
of F&V are associated with a lower risk of hypertension,348,349 obesity,350-352 and T2D,353 
all of which are established risk factors for CVD.354 Besides, Dauchet et al. (2006)355 in a 
meta-analysis that included nine studies with 91,379 men, 129,701 women, and 5,007 
CHD events, showed that the risk of CHD was decreased by 4% (p=0.0027) for each 
additional portion per day of F&V.  
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 Concerning cross-sectional studies in regards to F&V intake and oxidative stress 
biomarkers, a higher F&V intake was independently associated with lower oxLDL, 8-
OHdG, and 8- iso-PGF2 α (p< 0.05) in 296 healthy middle-aged men with BMI of 
25.8±3.5 kg/m2.250 In another study, 266 healthy subjects (age=22±3 y; BMI=22.0±2.7 
kg/m2) were enrolled to investigate the potential relationships of dietary TAC with 
oxidative stress markers. Dietary TAC was inversely associated with oxLDL 
concentration (p<0.05), suggesting a putative role of antioxidant rich-diet in the linkage 
between redox state and atherogenesis at an early stage.356 Moreover, in a 
epidemiological study carried out by Pitsavos et al. (2005),357 the effect of a diet score 
based on the Mediterranean diet on total antioxidant capacity (TAC) was examined in 
3042 participants aged 18–89 y from Greece who had no clinical evidence of CVD. 
Outcomes revealed that TAC was positively correlated with diet score, and participants in 
the highest tertile of the diet score had, on average, 11% higher TAC levels and 19% 
lower oxLDL concentrations than participants in the lowest tertile (p<0.01). TAC was 
positively correlated with consumption of F&V (R=0.34 and R= 0.31 respectively, 
p<0.001 for both). In case of adolescents, Holt et al. (2009) 358 determined whether 
greater intakes of F&V were inversely associated with urinary 8-iso prostaglandin F2α in 
285 adolescent boys and girls aged 13 to 17 y. Although weak, urinary F2-isoprostane 
was significantly inversely correlated with intakes of total F&V (R=-0.13, p<0.05). 
Based on this kind of cross-sectional studies, interventions designed to increase 
F&V intake have been promoted in all age groups. In a systematic review of the 
effectiveness of interventions, 44 studies (mainly from developed countries) were 
analyzed and stratified by study setting.359 In primary prevention interventions in healthy 
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adults, F&V intake was increased by approximately 0.1–1.4 serving/d, while larger 
effects were found in individuals with preexisting health disorders. Consistent beneficial 
effects were observed during different interventions, suggesting that small increases in 
F&V intake were possible in population subgroups by a variety of approaches.  
 Few interventions have centered on dietary patterns that increase F&V intake in 
regards to oxidative stress biomarkers. For instance, 79 adult participants with metabolic 
syndrome and hyperglycemia were randomly assigned to two low-calorie diets (−30% 
energy): the control diet based on the AHA criteria; and the RESMENA diet (Metabolic 
Syndrome Reduction in Navarra diet), characterized by an increase of meal frequency 
(seven-times/day), low glycemic load, high antioxidant capacity, and high n-3 fatty acids 
content. Changes in oxLDL were inversely associated to dietary TAC (R=-0.310, p = 
0.032) and fruit consumption (R=-0.304, p=0.028).360 However, correlations in the 
RESMENA study were simple and partial correlations, without taking into account the 
correlation within subjects, which is the correct analysis for the repeated measures design 
in this interventional study due to the dependence of data among time measurements for 
each participant. 
 In children, there are enough interventions centered on increasing F&V intake. 
Although with the same main aim of augmenting F&V dietary intake, pediatric 
interventions have differed in several aspects such as the settings, with some based on the 
school environment,361-363 others on community-based and family-based 
environments,271,364 and some others using both schools- and community-based 
approaches.365 Another aspect is the method of delivery, either using motivational 
intervention,366 telephone-based,367 peer-led,368,369 rewards-led,370,371 social messages-
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led,372 gardening,373 etc. Some interventions have focused on specific ethnic groups such 
as African-American,374 Chinese-American,364 Hispanics,271,280 children with migration 
background,361 etc. Furthermore, outcomes have differed with some interventions 
showing no F&V intake increases over time,375 while others showing successful 
increases.372 
 In the aforementioned pilot study performed by our research group120 in 15 obese 
participants using the ELSC program that was applied during this study, outcomes 
showed that responders and non-responders did not differ with regard to F&V intake. 
Comparing with the present study, significant increases in fresh F&V intake were found, 
with significant decreases in oxLDL, as well as no significant increases in oxHDL. It is 
unknown if differences in the intake of fresh F&V observed in both studies were related 
to the awareness of the disease. Sample from this intervention was at high-risk, due to the 
severity of prediabetes and obesity together, compared to obese participants from Ryder 
et al.120 The prediabetes condition in the present study might lead to an increased 
awareness of both the disease severity and the necessity of making lifestyle changes. 
Although not measured during the present intervention, awareness of the disease has been 
identified in health conditions such as heart diseases as one of the main factors involved 
in seeking prompt treatment.376,377 In a study detecting sociocultural and familial factors 
to prevent childhood obesity in 6-to-10 y-old children, Bruss et al. (2003)378 identified 
limited awareness of disease and its relationship to diet as stress factors for appropriate 
child-feeding practices, factors that seem to create personal, intergenerational, and intra-
family conflict, with consequent ineffective child-feeding practices.  
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On the other hand, adherence may be another factor that could influence F&V 
intake in the pilot intervention compared to the present study. However, both the pilot 
study reported by Ryder et al.120 and the current intervention lacked a gold-standard 
measure of behavior to infer adherence. There is a lack of effective methods to measure 
adherence to diet in the childhood obesity context.379 Besides, insights from six European 
studies helped to identify barriers to the implementation of dietary and PA 
recommendations in women and children. Psychological factors in women, such as a 
greater sense of control and having higher levels of food involvement allowed women to 
be empowered to eat more healthily and to feed their children better. Moreover, older 
women and those with higher educational attainment had better diets for themselves and 
for their children. In addition, living in more disadvantaged circumstances was associated 
with poorer diets, and mothers in such circumstances appear to have lower levels of food 
involvement.380 All these factors could differentially influence both the present study and 
the pilot study. Therefore it would be important in future studies to take into account 
these psychological factors in the family involved in the intervention, especially in the 
mother.  
Correlations between changes in dietary intake of F&V and changes in oxidative 
biomarkers during lifestyle interventions in children are very scarce. Only the study 
carried out by Rendo-Urteaga et al. (2014)113 evaluated oxidative status (TAC) in 
overweight/obese children after an aforementioned 10-week weight loss intervention in 
which individualized fixed full-day meal diet was provided. Interestingly, basal serum 
TAC values significantly predicted the decreases in urinary F2 isoprostane after the 
program in the HR group, and the relationships between oxidative markers and 
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antioxidants dietary intake were more favorable in the HR than in the low responders 
(LR). Non-significant associations between oxidative status markers and changes in 
adiposity and biochemical parameters were found. Outcomes indicated that in terms of 
oxidative status, basal levels of TAC were more important predicting change in oxidative 
markers. These results and findings from the present study suggested that frequent intake 
of specific foods with a high TAC content (such as fruits and vegetables, among others) 
should be encouraged through life, but especially at young ages, to assure optimal 
consumption of antioxidants.  
Similar to the statistical correlation analysis used by the previously mentioned 
RESMENA study in adults, Rendo-Urteaga et al. also used partial correlations to 
calculate the association between changes, which according to the assumption of the 
dependence of subjects within the time measurements, it is not the correct statistical 
correlation analysis for this kind of within-subjects design. 
 Despite not focused on an oxidative marker, Woolcott et al. (2013)381 centered to 
determine if changes in PA were associated with changes in F&V intake in a prospective 
cohort with 700 adults from Hawaii. Covariance Model Analysis revealed no mean 
within-individual correlation between changes in PA and changes in F&V intake over 
time (R=0.03, p>0.05), even though between-individual Pearson´s correlations showed 
that individuals with a higher mean PA duration tended to eat more F&V (R=0.30, 
p<0.0001). It is important to note that unlike some studies previously discussed and 
similar to the statistical analysis used by Woolcott et al., within-subjects correlations 
between changes in each oxidized lipoprotein and changes in fresh F&V intake, adjusted 
for changes in VO2max, were calculated during the present study. Since participants were 
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analyzed at each time (pre- and post- intervention), using within-subjects correlation 
analysis did not violate the assumption of the dependence of measurements. This analysis 
is especially relevant considering that most studies that reported correlations between 
changes used Pearson or Spearman correlation, which was not the correct statistical 
analysis.  
In the present intervention, it was hypothesized that changes in both oxLDL and 
oxHDL would be related to intake of fresh F&V, independent of the improvements in 
VO2max. However, weak and non-significant correlations were detected between 
changes in fresh F&V intake and oxLDL, and with oxHDL, both adjusted for VO2max 
changes. Although correlations were weak and not significant, this analysis allowed 
concluding that the ELSC lifestyle intervention applied on obese prediabetic Latino youth 
promoted significant reductions in oxLDL, and no significant increases in oxHDL, with 
significant increases in both fresh F&V intake and VO2max. Additionally, the 
intervention was able to improve anthropometric and cardiometabolic outcomes. These 
findings suggest that changes in oxidized lipoproteins were promoted by mechanisms 
different that only those provided by the intake of fresh F&V, and that effects were not 
independent of improvements on CRF. 
 
5.5 Strengths and Limitations 
 The present study has a number of strengths worth mentioning. No attrition rate 
was documented since all participants were included as completers. The range of 
attendance was between 58-100% of sessions, which was similar to the attendance 
reported in other community-based family interventions that have shown success.382 
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Sample was homogeneous in terms of ethnicity, age, prediabetes and degree of obesity. 
The homogeneity of the sample was due to the rigorous inclusion criteria used during the 
present study.  
In terms of the study design, the quasi-experimental study has advantages and 
disadvantages. Focusing on the strengths of the study, this design used repeated measures 
(also called within-subjects design), which establishes that each participant takes part of 
each measurement time, allowing for an adequate control of individual differences and 
consequently producing small random error effects. A medium effect size for one sample 
t-test of d=0.5675 was calculated, using a total sample size of 35 participants, a 
significance level of 0.05, and power =0.95. Concerning the statistical analysis, paired t-
test for comparisons between pre-and post-intervention measurements was used, and 
within-subjects correlations were calculated between changes in oxidized lipoproteins 
and changes in fresh F&V intake adjusted for changes in VO2max. Using this design 
allowed to take into account the dependence of subjects, since participants were the same 
in both pre- and post-intervention measurements. This strength is especially meaningful 
since most reported correlations between changes in lifestyle interventions have used 
Pearson or Spearman correlation, assuming independence of measurements and therefore 
violating the assumption of within-subjects or repeated-measures correlation.  
 Another strength is the use of official laboratory measurement techniques 
according to the respective guidelines, since this study included a comprehensive 
evaluation of cardiometabolic outcomes, as well as anthropometric and behavioral 
variables. Moreover, with pre- and post-intervention measurements of dietary intake and 
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CRF, the potential influence of dietary intake of fresh F&V was taken into account on 
changes in oxidative stress biomarkers, adjusted for VO2max. 
 Concerning limitations, the most important disadvantage of quasi-
experimental designs is lack of a control group. It is well know that randomized control 
trials are the gold standard for interventional studies. However, the inclusion of controls 
is not ethically valid in studies with pediatric population at high risk for cardiometabolic 
conditions, owing to ethical concerns of treatment delay.121 Thus, although not optimal, 
quasi-experimental designs with paired samples are frequently used in studies with the 
population at high risk. One possibility to improve the design in the future to be more 
rigorous in testing our intervention in children at-risk could be the inclusion of usual care 
as an alternative of comparison group. In this way a randomized trial could be 
implemented to test the present intervention, compared to the usual care program. Other 
designs such as the crossover design in prediabetic youth are not useful since the 
potential long-term effect of the intervention may represent a carry over effect.  
Another limitation of quasi-experimental pre- and post-intervention studies is that 
repeated-measures designs have a risk of order effects, with participants maybe starting to 
suffer fatigue and/or carryover effects. Constant psychological motivation was offered 
throughout the current intervention to counteract order effects, as well as compensations 
and rewards for attendance. In addition, although within-subjects designs allow for small 
sample sizes, a large sample would have resulted in a higher effect size. The current 
sample size of the present study was part of the bigger sample from the parent study, thus 
a small sample size was expected considering the prevalence of prediabetes in this young 
population.  
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 Another limitation is the elevated daily variability of the lipid outcome measures. 
Biological rather than analytical variability is a major contributor to the inaccuracy of CV 
risk assessments based on measurement of lipids and lipoproteins.383 Although in this 
study multiple-days samples could not been collected due to the time and cost 
implications, other strategies were used as an attempt to reduce within-person variability, 
such as fasting for at least 10 hours and the recommendation of a low-fat diet the 
previous day of blood sampling. Also, in order to reduce between-persons variability, 
participants were recruited with strict inclusion criteria to have a homogeneous sample 
regarding age, ethnicity, and obesity degree.   
With respect to dietary intake, a food screener for ages 2-17y was used, the Brief 
Dietary Assessment tool for children 2-to-17 y. Since this is a FFQ for self-administration 
by adolescents, the present study relied on self-report data to estimate children's intake by 
food group. This tool has few disadvantages, mainly related to the limited checklist of 
foods and beverages, however this screener was especially designed to assess children's 
intake by food group, with focus on the intake of F&V. Among cons, this questionnaire 
relies upon the respondent’s memory for being a retrospective method, and arbitrary 
groupings of foods may not correspond to the perception of the respondent. Moreover, 
exclusion of foods popular to specific ethnic minority groups such as Mexican-
Americans, which represents most of the participants, would skew the data. Nevertheless, 
this questionnaire was an adequate option since it is adapted to children and adolescents 
and the food checklist is based on NHANES dietary data and mainly focused on F&V 
consumption, which was one of the main outcomes of this intervention. Moreover, this is 
a semi-quantitative FFQ with collected portion size information as standardized portions 
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or as a choice of portion sizes. A representative of “habitual” intake, this is the preferable 
method of measuring food intake with very high day-to-day variability. 
Regarding the panel of biomarkers used here, they were not exhaustive and other 
potential markers of oxidative stress and lipoprotein function were not measured. 
However, there is a paucity of evidence in oxidized lipoproteins as early markers of 
oxidative stress and atherosclerotic risk, thus in this sense this study and statistical 
analysis was novel. Moreover, the inclusion of conventional cardiometabolic variables 
suggested that the intervention was successful in reverting the prediabetic status of most 
participants and consequently decreasing CVD risk.  
 
5.6 Future Research 
 The present study was design to evaluate the effects of a lifestyle and T2D-
prevention intervention for obese prediabetic Latino adolescents on levels of oxidized 
lipoproteins as early biomarkers of oxidative stress. Future research evaluating the 
present intervention should improve the study design including a randomized design in 
which a usual care group could be compared to the intervention group. In addition to this, 
a larger sample size could be included to have a higher effect size. Moreover, long-term 
effects could be evaluated including follow-up measurements in the future design. 
Decreases in oxLDL were observed during the present study according to the 
proposed hypothesis. However, results from oxHDL were unexpected, showing non-
significant increases after the intervention. Future research evaluating oxHDL should 
include other biomarkers of lipoprotein metabolism and function such as the degree of 
oxidation, functionality of HDL, cholesterol efflux capacity, enzymatic activity during 
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reverse cholesterol transport, apoproteins, and some others. Although few, evidence from 
studies regarding HDL have shown these potential variables as better indicators of the 
antiatherosclerotic properties of HDL. Regarding the effect of interventions on the 
oxidative stress process, meaningful variables related to the overproduction of ROS may 
be included, such as MPO and PON enzymes and oxidant metabolites. It would also be 
interesting to consider the effects of the intervention on some other indicators of more 
direct CVD risk, such as endothelial dysfunction and antithrombotic properties, among 
others.  
Diet assessment using the corresponding FFQ may allow evaluating some other 
nutrients and compounds, such as fiber intake. Fiber is recognized as a source of diverse 
antioxidants and as a component that affects the glycemic response and blood lipids of 
individuals. Therefore, future approaches may include the effects of fiber dietary intake 
on the antioxidant status of participants, as well as its influence on cardiometabolic 
variables. Moreover, dietary patters instead of individual food groups or nutrients are 
recently recognized as the main contributors to the decrease in CVD risk, thus future 
studies should investigate the effects of dietary patterns on the risk for CVD. 
Finally, future research should be done applying translational science to implement 
lifestyle modifications to more people at the community, to get meaningful health 
outcomes in this young group at high risk for T2D and CVD. 
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CHAPTER 6. CONCLUSION  
 
 Effective interventions for improving oxidative stress and atherosclerotic 
biomarkers are necessary as CVD represents the leading cause of morbidity and mortality 
worldwide. Lifestyle modification constitutes an excellent approach to prevent T2D and 
its concomitant CVD complications. In youth, lifestyle interventions are outstanding 
options since pharmacological and surgical treatments are limited. The purpose of the 
present study was to evaluate the effects of a lifestyle T2D-prevention intervention for 
obese Latino adolescents with prediabetes on levels of oxidized lipoproteins as early 
biomarkers of oxidative stress. We chose oxLDL and oxHDL as these early biomarkers 
would better reflect both oxidative stress and atherosclerotic risk. We hypothesized that 
levels of both lipoproteins would be significantly lower after the intervention, and that 
changes in fresh F&V intake will be inversely and independently correlated with changes 
in oxLDL and oxHDL, after controlling for changes in VO2max. Previous investigations 
have analyzed the effects of lifestyle modification in obese but otherwise healthy kids. To 
our knowledge, this study is the first specifically designed to test the synergistic effect of 
diet and PA modification on both oxidized lipoproteins in prediabetic obese adolescents. 
Additionally, this research adds to previous work by including measurements of behavior 
such as changes in fresh F&V intake, as potential correlates of changes in each oxidized 
lipoprotein. 
 The present study showed significant decreases in oxLDL levels; however, the 
intervention failed to show reductions in oxHDL levels. Following the intervention, 
dietary fresh F&V intake was significantly increased, as well as VO2max. Weak, non-
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significant within-subjects correlations were found between changes in oxidized 
lipoproteins and fresh F&V intake after adjustment for VO2max changes. In addition to 
these outcomes, the lifestyle intervention resulted in improvements in most 
anthropometric and cardiometabolic variables suggesting a reduced risk of CVD. Main 
cardiometabolic changes were observed in 2-hour glucose and 2-hour insulin during an 
OGTT, resulting in 23 out of 35 participants (66%) considered as normal glucose tolerant 
immediately after the intervention. All variables in the lipid panel significantly decreased 
except for LDL-c, which was not statistically changed.  
Lack of detecting a significant correlation between changes in oxidized 
lipoproteins and changes in fresh F&V intake could be related to the fact that, although 
components of F&V have antioxidant properties that counteract oxidative stress, overall 
diet patterns rather than single foods have been recently recognized as the leading dietary 
factor reducing CVD risk. New research challenges must focus on elucidating behavior 
change and subsequent biochemical mechanisms by which healthy diet and PA patterns 
may reduce CV risk. In addition, biochemical and functional aspects of lipoproteins 
would be meaningful variables worth including in future studies of this early age group.  
With these mechanisms defined, their promotion in practical, real-life lifestyle 
interventions can be supported. 
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